| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP5F1D MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 ABCA2 ATP8B4 MYH13 PSMC1 CHD3 KIF24 DDX11 HSPA1A HSPA1B DDX11L8 DYNC1H1 HSPD1 DNHD1 ABCC1 DDX12P EP400 DNAH10 RNF213 RFC2 MMAA CHD5 MACF1 MYH15 CDC6 | 9.77e-11 | 614 | 258 | 31 | GO:0140657 |
| GeneOntologyMolecularFunction | actin filament binding | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 HIP1 MYL4 MYH13 SPTAN1 ACTN4 SPTBN5 TLN2 PLS1 SYNE1 MACF1 MYH15 | 7.05e-09 | 227 | 258 | 17 | GO:0051015 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYH13 SPTAN1 ESRRG RYR2 RYR3 PHKA1 PHKA2 CNGA2 UBR4 CAMK1 MYH15 | 8.58e-09 | 230 | 258 | 17 | GO:0005516 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP5F1D MYH4 MYH7 MYH8 ABCA2 ATP8B4 PSMC1 CHD3 DDX11 HSPA1A HSPA1B DDX11L8 DYNC1H1 HSPD1 ABCC1 DDX12P DNAH10 RNF213 RFC2 MMAA CHD5 MACF1 CDC6 | 1.62e-08 | 441 | 258 | 23 | GO:0016887 |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.44e-08 | 38 | 258 | 8 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 HIP1 MYL4 NEK6 MYH13 MARK1 MARK3 SPTAN1 ACTN4 ADGRV1 KIF24 SPTBN5 PTPRC NFKB1 TLN2 DNM1 UTRN CNGA3 PLS1 DNM2 RTCB HAP1 SYNE1 SPAG5 SMTN CCDC88A ANKRD1 DNM3 GOLGA8B MACF1 MYH15 MARK2 GOLGA8A | 2.92e-08 | 1099 | 258 | 38 | GO:0008092 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYH13 KIF24 DYNC1H1 DNHD1 DNAH10 MYH15 | 4.26e-08 | 118 | 258 | 12 | GO:0003774 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP5F1D MYH4 MYH7 MYH8 ABCA2 ATP8B4 PSMC1 CHD3 DDX11 DNM1 HSPA1A HSPA1B DDX11L8 DYNC1H1 DNM2 HSPD1 ABCC1 DDX12P DNAH10 RNF213 RFC2 RAB41 MMAA CHD5 DNM3 MACF1 IRGC CDC6 | 9.75e-07 | 775 | 258 | 28 | GO:0017111 |
| GeneOntologyMolecularFunction | DNA replication origin binding | 2.59e-06 | 18 | 258 | 5 | GO:0003688 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP5F1D MYH4 MYH7 MYH8 ABCA2 ATP8B4 PSMC1 CHD3 DDX11 DNM1 HSPA1A HSPA1B DDX11L8 DYNC1H1 DNM2 HSPD1 ABCC1 DDX12P DNAH10 RNF213 RFC2 RAB41 MMAA CHD5 DNM3 MACF1 IRGC CDC6 | 4.49e-06 | 839 | 258 | 28 | GO:0016462 |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 HIP1 MYL4 MYH13 SPTAN1 ACTN4 SPTBN5 TLN2 UTRN PLS1 SYNE1 SMTN CCDC88A MACF1 MYH15 | 4.58e-06 | 479 | 258 | 20 | GO:0003779 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP5F1D MYH4 MYH7 MYH8 ABCA2 ATP8B4 PSMC1 CHD3 DDX11 DNM1 HSPA1A HSPA1B DDX11L8 DYNC1H1 DNM2 HSPD1 ABCC1 DDX12P DNAH10 RNF213 RFC2 RAB41 MMAA CHD5 DNM3 MACF1 IRGC CDC6 | 4.59e-06 | 840 | 258 | 28 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP5F1D MYH4 MYH7 MYH8 ABCA2 ATP8B4 PSMC1 CHD3 DDX11 DNM1 HSPA1A HSPA1B DDX11L8 DYNC1H1 DNM2 HSPD1 ABCC1 DDX12P DNAH10 RNF213 RFC2 RAB41 MMAA CHD5 DNM3 MACF1 IRGC CDC6 | 4.59e-06 | 840 | 258 | 28 | GO:0016818 |
| GeneOntologyMolecularFunction | triplex DNA binding | 8.45e-06 | 4 | 258 | 3 | GO:0045142 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 2.09e-05 | 5 | 258 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 4.93e-05 | 130 | 258 | 9 | GO:0005200 | |
| GeneOntologyMolecularFunction | ligase activity, forming phosphoric ester bonds | 7.18e-05 | 7 | 258 | 3 | GO:0016886 | |
| GeneOntologyMolecularFunction | D2 dopamine receptor binding | 7.18e-05 | 7 | 258 | 3 | GO:0031749 | |
| GeneOntologyMolecularFunction | structural molecule activity | MYH8 HIP1 NUP85 ERC1 SPTAN1 HAPLN4 ACTN4 TLN2 BFSP2 PLS1 KRT15 KRT19 KRT81 KRT82 KRT83 KRT86 LAMB2 ODF2 SMTN HMCN1 VWA5A DNM3 MACF1 ERC2 CRYBG3 | 2.39e-04 | 891 | 258 | 25 | GO:0005198 |
| GeneOntologyMolecularFunction | calcium channel activity | 2.77e-04 | 129 | 258 | 8 | GO:0005262 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | TRIT1 ETF1 CHD3 DDX11 AARS2 MED21 DDX11L8 DDX12P EP400 RTCB SLFN12 RFC2 REXO2 LIG4 RNASEL TYW1B CHD5 RTCA HARS1 CPSF3 | 2.90e-04 | 645 | 258 | 20 | GO:0140640 |
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 3.26e-04 | 11 | 258 | 3 | GO:0043139 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.37e-04 | 28 | 258 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | structural constituent of synapse-associated extracellular matrix | 4.95e-04 | 3 | 258 | 2 | GO:0150043 | |
| GeneOntologyMolecularFunction | denatured protein binding | 4.95e-04 | 3 | 258 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 6.51e-04 | 31 | 258 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 6.98e-04 | 14 | 258 | 3 | GO:0051880 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 7.90e-04 | 151 | 258 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | myosin binding | 8.19e-04 | 85 | 258 | 6 | GO:0017022 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 8.30e-04 | 33 | 258 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | phosphorylase kinase activity | 9.81e-04 | 4 | 258 | 2 | GO:0004689 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 9.81e-04 | 4 | 258 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | TRIT1 ETF1 AARS2 MED21 DDX11L8 DDX12P RTCB SLFN12 REXO2 RNASEL TYW1B RTCA HARS1 CPSF3 | 1.12e-03 | 417 | 258 | 14 | GO:0140098 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.29e-03 | 37 | 258 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.33e-03 | 127 | 258 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.51e-03 | 18 | 258 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 1.62e-03 | 5 | 258 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 2.26e-03 | 43 | 258 | 4 | GO:0030280 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.32e-03 | 140 | 258 | 7 | GO:0099094 | |
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 2.39e-03 | 21 | 258 | 3 | GO:0061676 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.41e-03 | 6 | 258 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 2.41e-03 | 6 | 258 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 2.41e-03 | 6 | 258 | 2 | GO:0055131 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 2.74e-03 | 22 | 258 | 3 | GO:0050321 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 2.74e-03 | 22 | 258 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | nucleoside monophosphate kinase activity | 3.12e-03 | 23 | 258 | 3 | GO:0050145 | |
| GeneOntologyMolecularFunction | 4 iron, 4 sulfur cluster binding | 3.14e-03 | 47 | 258 | 4 | GO:0051539 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound kinase activity | 3.14e-03 | 47 | 258 | 4 | GO:0019205 | |
| GeneOntologyBiologicalProcess | organelle assembly | MYH6 MYH7 NEK6 KIF24 AK7 CFLAR LRGUK PIK3C3 GORAB TTC12 ATXN10 HSPA1A HSPA1B PLS1 DYNC1H1 WDR44 DNM2 DNHD1 VPS37C LIMD1 KRT19 HAP1 CEP162 SYNE1 CNTRL RTTN RNF213 ODF2 RFX2 SPAG5 WDR19 CCDC88A PLA2G4C CELSR3 MTOR ANKRD1 GOLGA8B TNKS C9orf72 SPAG17 GOLGA8A | 7.25e-10 | 1138 | 256 | 41 | GO:0070925 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYH6 MYH7 HIP1 SPTAN1 ACTN4 PFDN2 KIF24 SPTBN5 CFLAR BFSP2 HSPA1A HSPA1B PLS1 DYNC1H1 ALOX15 DNM2 KRT15 RB1 KRT19 KRT81 KRT82 KRT83 KRT86 ARHGEF18 CIT P3H4 CCDC88A MTOR ANKRD1 GOLGA8B C9orf72 GOLGA8A | 3.52e-07 | 957 | 256 | 32 | GO:0097435 |
| GeneOntologyBiologicalProcess | muscle filament sliding | 7.68e-07 | 15 | 256 | 5 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 2.13e-06 | 18 | 256 | 5 | GO:0033275 | |
| GeneOntologyBiologicalProcess | cilium organization | KIF24 AK7 LRGUK GORAB TTC12 ATXN10 WDR44 DNM2 DNHD1 HAP1 CEP162 SYNE1 CNTRL RTTN ODF2 RFX2 WDR19 CCDC88A CELSR3 SPAG17 | 2.29e-06 | 476 | 256 | 20 | GO:0044782 |
| GeneOntologyBiologicalProcess | microtubule-based process | NEK6 MARK1 CHD3 LYST KIF24 AK7 LRGUK TTC12 VPS13A HSBP1 TACC1 HSPA1A HSPA1B DYNC1H1 DNM2 DNHD1 DNAH10 HAP1 CNTRL RTTN ODF2 SPAG5 WDR19 IGBP1 CCDC88A GOLGA8B MACF1 IRGC TNKS MARK2 SPAG17 GOLGA8A | 3.04e-06 | 1058 | 256 | 32 | GO:0007017 |
| GeneOntologyBiologicalProcess | cilium assembly | KIF24 AK7 LRGUK GORAB TTC12 ATXN10 WDR44 DNM2 DNHD1 HAP1 CEP162 SYNE1 CNTRL ODF2 RFX2 WDR19 CCDC88A CELSR3 SPAG17 | 3.17e-06 | 444 | 256 | 19 | GO:0060271 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | HIP1 ATR ERC1 ACTN4 PFDN2 ANKRD27 TIAM2 DDX11 CFLAR PTPRC C4A C4B DNM1 HSPA1A HSPA1B DYNC1H1 PLXNB1 ALOX15 DNM2 RB1 HAP1 SYNE1 CAMK1 NCAPH SPAG5 LIG4 CCDC88A NOX1 MTOR ANKRD1 DNM3 GOLGA8B MACF1 ERC2 TNKS MARK2 GOLGA8A | 6.22e-06 | 1366 | 256 | 37 | GO:0051130 |
| GeneOntologyBiologicalProcess | establishment of sister chromatid cohesion | 7.14e-06 | 11 | 256 | 4 | GO:0034085 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | MARK1 SARM1 KIF24 ANKRD27 STX1B TIAM2 CFLAR PLS1 PLXNB1 WDR44 DNM2 HAP1 SYNE1 CAMK1 GRIN2B ODF2 CIT CCDC88A NOX1 MTOR ANKRD1 RTCA DNM3 GOLGA8B MACF1 MARK2 GOLGA8A | 7.30e-06 | 846 | 256 | 27 | GO:0120035 |
| GeneOntologyBiologicalProcess | intracellular transport | ABCA2 NUP85 ERC1 ACTN4 COG3 LYST ANKRD27 PTGS2 STX1B SNX13 PIK3R4 SPTBN5 GRAMD1B PIK3C3 MCM3AP VPS13A USP7 HSBP1 TACC1 TIMM44 HSPA1A HSPA1B DYNC1H1 KPNA3 KPNA4 VPS37C HAP1 SYNE1 AHCTF1 CAMK1 SPAG5 RAB41 WDR19 CCDC88A NEMF GOLGA8B C9orf72 SPAG17 GOLGA8A | 8.29e-06 | 1496 | 256 | 39 | GO:0046907 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | MYH6 MYH7 NEK6 CFLAR HSPA1A HSPA1B PLS1 DYNC1H1 LIMD1 KRT19 RTTN RNF213 SPAG5 PLA2G4C ANKRD1 GOLGA8B TNKS C9orf72 GOLGA8A | 8.33e-06 | 475 | 256 | 19 | GO:0140694 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | MARK1 SARM1 KIF24 ANKRD27 STX1B TIAM2 CFLAR PLS1 PLXNB1 WDR44 DNM2 HAP1 SYNE1 CAMK1 GRIN2B ODF2 CIT CCDC88A NOX1 MTOR ANKRD1 RTCA DNM3 GOLGA8B MACF1 MARK2 GOLGA8A | 1.04e-05 | 863 | 256 | 27 | GO:0031344 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | NUP85 KIF24 AK7 LRGUK GORAB TTC12 ATXN10 PLS1 WDR44 DNM2 DNHD1 HAP1 CEP162 SYNE1 CNTRL ODF2 RFX2 WDR19 CCDC88A CELSR3 MTOR DNM3 SPAG17 | 1.14e-05 | 670 | 256 | 23 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | NUP85 KIF24 AK7 LRGUK GORAB TTC12 ATXN10 PLS1 WDR44 DNM2 DNHD1 HAP1 CEP162 SYNE1 CNTRL ODF2 RFX2 WDR19 CCDC88A CELSR3 MTOR DNM3 SPAG17 | 1.62e-05 | 685 | 256 | 23 | GO:0030031 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | MARK1 SARM1 ANKRD27 STX1B TIAM2 CFLAR PLXNB1 HAP1 SYNE1 CAMK1 CIT CCDC88A NOX1 MTOR ANKRD1 RTCA DNM3 GOLGA8B MACF1 MARK2 GOLGA8A | 2.80e-05 | 612 | 256 | 21 | GO:0010975 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 3.26e-05 | 99 | 256 | 8 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 3.51e-05 | 100 | 256 | 8 | GO:0045103 | |
| GeneOntologyBiologicalProcess | endomembrane system organization | MYH2 ATP8B4 NEK6 ATR ERC1 COG3 SNAP47 LYST STX1B SPTBN5 PIK3C3 DNM1 DNM2 VPS37C SYNE1 UBR4 RFX2 CIT NOX1 GOLGA8B ERC2 GOLGA8A | 3.65e-05 | 672 | 256 | 22 | GO:0010256 |
| GeneOntologyBiologicalProcess | cellular heat acclimation | 3.68e-05 | 6 | 256 | 3 | GO:0070370 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 4.04e-05 | 75 | 256 | 7 | GO:0045109 | |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | KIF24 HSPA1A HSPA1B DYNC1H1 WDR44 DNM2 HAP1 SYNE1 ODF2 SPAG5 CCDC88A MTOR C9orf72 | 5.13e-05 | 280 | 256 | 13 | GO:1902115 |
| GeneOntologyBiologicalProcess | neuron projection development | UBE4B MARK1 SARM1 ADGRV1 TNFRSF21 ANKRD27 STX1B TIAM2 CFLAR VPS13A ATXN10 PLS1 PLXNB1 DNM2 RB1 HAP1 SYNE1 LAMB2 CAMK1 CIT CCDC88A NOX1 CELSR3 MTOR EFHD1 ANKRD1 RTCA DNM3 GOLGA8B MACF1 MARK2 C9orf72 GOLGA8A | 5.94e-05 | 1285 | 256 | 33 | GO:0031175 |
| GeneOntologyBiologicalProcess | heat acclimation | 6.37e-05 | 7 | 256 | 3 | GO:0010286 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 6.65e-05 | 81 | 256 | 7 | GO:0034605 | |
| GeneOntologyBiologicalProcess | ribonucleoside triphosphate metabolic process | ATP5F1D MYH4 MYH6 MYH7 MYH8 NDUFAB1 AK5 UCKL1 DHTKD1 HSPA1A HSPA1B MTOR ENO2 | 7.32e-05 | 290 | 256 | 13 | GO:0009199 |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 7.80e-05 | 36 | 256 | 5 | GO:0007274 | |
| GeneOntologyBiologicalProcess | ATP metabolic process | ATP5F1D MYH4 MYH6 MYH7 MYH8 NDUFAB1 AK5 DHTKD1 HSPA1A HSPA1B MTOR ENO2 | 9.43e-05 | 257 | 256 | 12 | GO:0046034 |
| GeneOntologyBiologicalProcess | protein localization to organelle | NUP85 ATR MARK3 SARM1 COG3 PTGS2 RYR2 PIK3R4 PIK3C3 VPS13A TIMM44 KPNA3 KPNA4 HSPD1 VPS37C RB1 SYNE1 NBEA SPAG5 CENPQ WDR19 ANKRD13A TRIM69 CCDC88A MTOR MACF1 TNKS RPA1 STAG3 | 9.53e-05 | 1091 | 256 | 29 | GO:0033365 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | NEK6 MARK1 CHD3 KIF24 AK7 LRGUK TTC12 TACC1 HSPA1A HSPA1B DYNC1H1 DNM2 CNTRL RTTN ODF2 SPAG5 CCDC88A GOLGA8B TNKS MARK2 SPAG17 GOLGA8A | 1.00e-04 | 720 | 256 | 22 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of inclusion body assembly | 1.17e-04 | 21 | 256 | 4 | GO:0090083 | |
| GeneOntologyBiologicalProcess | nucleoside triphosphate metabolic process | ATP5F1D MYH4 MYH6 MYH7 MYH8 NDUFAB1 AK5 UCKL1 DHTKD1 HSPA1A HSPA1B MTOR ENO2 | 1.30e-04 | 307 | 256 | 13 | GO:0009141 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | NEK6 ATR ERC1 SPTAN1 PFDN2 KIF24 ANKRD27 DDX11 SPTBN5 USP7 HSPA1A HSPA1B DYNC1H1 PLXNB1 ALOX15 WDR44 DNM2 RB1 HAP1 SYNE1 ARHGEF18 ODF2 NCAPH CIT SPAG5 LIG4 CCDC88A MTOR ERC2 TNKS MARK2 CDC6 C9orf72 | 1.35e-04 | 1342 | 256 | 33 | GO:0033043 |
| GeneOntologyBiologicalProcess | chromosome organization | NEK6 ATR DDX11 USP7 HSPA1A HSPA1B DDX11L8 DDX12P RB1 RFC2 NCAPH CIT P3H4 SPAG5 LIG4 GOLGA8B TNKS CDC6 RPA1 GOLGA8A STAG3 | 1.41e-04 | 686 | 256 | 21 | GO:0051276 |
| GeneOntologyBiologicalProcess | neuron development | UBE4B MARK1 SARM1 ADGRV1 TNFRSF21 ANKRD27 STX1B TIAM2 CFLAR VPS13A ATXN10 CNGA3 PLS1 PLXNB1 HAND2 DNM2 RB1 HAP1 SYNE1 LAMB2 CAMK1 CIT CCDC88A NOX1 CELSR3 MTOR EFHD1 ANKRD1 RTCA DNM3 GOLGA8B MACF1 MARK2 C9orf72 GOLGA8A | 1.42e-04 | 1463 | 256 | 35 | GO:0048666 |
| GeneOntologyBiologicalProcess | muscle contraction | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYL4 MYH13 PTGS2 RYR2 RYR3 HSBP1 UTRN SMTN MTOR | 1.54e-04 | 400 | 256 | 15 | GO:0006936 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | NEK6 HSPA1A HSPA1B DYNC1H1 RB1 NCAPH CIT P3H4 SPAG5 CENPQ GOLGA8B CDC6 GOLGA8A STAG3 | 1.56e-04 | 356 | 256 | 14 | GO:0098813 |
| GeneOntologyBiologicalProcess | muscle system process | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYL4 MYH13 CMYA5 PTGS2 RYR2 RYR3 CFLAR HSBP1 UTRN HAND2 SMTN MTOR | 1.77e-04 | 547 | 256 | 18 | GO:0003012 |
| GeneOntologyBiologicalProcess | sister chromatid cohesion | 1.83e-04 | 67 | 256 | 6 | GO:0007062 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | ATP5F1D MYH4 MYH6 MYH7 MYH8 ABCA2 SARM1 NDUFAB1 LYST AK7 PIK3R4 LRGUK TTC7B PIK3C3 AK5 UCKL1 MDH1B DHTKD1 HSPA1A HSPA1B ALOX15 PITPNM2 NFS1 REXO2 NOX1 PLA2G4C MTOR FLAD1 ENO2 | 2.08e-04 | 1142 | 256 | 29 | GO:0019637 |
| GeneOntologyBiologicalProcess | purine ribonucleoside triphosphate metabolic process | ATP5F1D MYH4 MYH6 MYH7 MYH8 NDUFAB1 AK5 DHTKD1 HSPA1A HSPA1B MTOR ENO2 | 2.31e-04 | 283 | 256 | 12 | GO:0009205 |
| GeneOntologyBiologicalProcess | synaptic vesicle budding from presynaptic endocytic zone membrane | 2.90e-04 | 11 | 256 | 3 | GO:0016185 | |
| GeneOntologyBiologicalProcess | purine nucleoside triphosphate metabolic process | ATP5F1D MYH4 MYH6 MYH7 MYH8 NDUFAB1 AK5 DHTKD1 HSPA1A HSPA1B MTOR ENO2 | 2.98e-04 | 291 | 256 | 12 | GO:0009144 |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | ATP5F1D MYH4 MYH6 MYH7 MYH8 SARM1 NDUFAB1 AK7 LRGUK AK5 UCKL1 MDH1B DHTKD1 HSPA1A HSPA1B REXO2 NOX1 MTOR FLAD1 ENO2 | 3.68e-04 | 684 | 256 | 20 | GO:0009117 |
| GeneOntologyBiologicalProcess | regulation of cilium assembly | 4.02e-04 | 108 | 256 | 7 | GO:1902017 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | ATP5F1D MYH4 MYH6 MYH7 MYH8 SARM1 NDUFAB1 AK7 LRGUK AK5 UCKL1 MDH1B DHTKD1 HSPA1A HSPA1B REXO2 NOX1 MTOR FLAD1 ENO2 | 4.19e-04 | 691 | 256 | 20 | GO:0006753 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH2 MYH4 MYH6 MYH7 MYH8 HIP1 SPTAN1 ACTN4 RYR2 SPTBN5 CFLAR TLN2 PLS1 ALOX15 DNM2 KRT19 ARHGEF18 CIT SMTN CCDC88A HMCN1 MTOR ANKRD1 C9orf72 | 4.51e-04 | 912 | 256 | 24 | GO:0030029 |
| GeneOntologyBiologicalProcess | vesicle scission | 4.57e-04 | 3 | 256 | 2 | GO:0099050 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | ANKRD27 TIAM2 CFLAR PLXNB1 DNM2 HAP1 CAMK1 CCDC88A NOX1 MTOR ANKRD1 DNM3 GOLGA8B MACF1 MARK2 GOLGA8A | 4.81e-04 | 494 | 256 | 16 | GO:0031346 |
| GeneOntologyBiologicalProcess | cell cycle process | NEK6 ATR CHD3 DDX11 PIK3R4 PTPRC PIK3C3 TACC1 ATXN10 HSPA1A HSPA1B DDX11L8 DYNC1H1 DNM2 CUL1 DDX12P RB1 AHCTF1 RTTN SLFN12 ODF2 NCAPH SKP2 CIT P3H4 SPAG5 CENPQ GOLGA8B TNKS CDC6 GOLGA8A CPSF3 STAG3 | 4.89e-04 | 1441 | 256 | 33 | GO:0022402 |
| GeneOntologyBiologicalProcess | spindle organization | NEK6 CHD3 TACC1 HSPA1A HSPA1B DYNC1H1 SPAG5 GOLGA8B TNKS GOLGA8A | 5.12e-04 | 224 | 256 | 10 | GO:0007051 |
| GeneOntologyBiologicalProcess | synaptic vesicle fusion to presynaptic active zone membrane | 5.60e-04 | 31 | 256 | 4 | GO:0031629 | |
| GeneOntologyBiologicalProcess | synaptic vesicle priming | 5.60e-04 | 31 | 256 | 4 | GO:0016082 | |
| GeneOntologyBiologicalProcess | vacuolar transport | LYST PIK3R4 SPTBN5 PIK3C3 VPS13A HSPA1A HSPA1B VPS37C C9orf72 | 5.66e-04 | 187 | 256 | 9 | GO:0007034 |
| GeneOntologyBiologicalProcess | mitotic spindle organization | 6.10e-04 | 151 | 256 | 8 | GO:0007052 | |
| GeneOntologyBiologicalProcess | skeletal muscle adaptation | 6.34e-04 | 32 | 256 | 4 | GO:0043501 | |
| GeneOntologyBiologicalProcess | vesicle fusion to plasma membrane | 6.34e-04 | 32 | 256 | 4 | GO:0099500 | |
| GeneOntologyBiologicalProcess | spindle assembly | 6.65e-04 | 153 | 256 | 8 | GO:0051225 | |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | HIP1 ABCA2 ERC1 ACTN4 ANKRD27 STX1B PTPRC USP7 C4A C4B DNM1 ALOX15 WDR44 DNM2 HAP1 SYNE1 ANKRD13A ERC2 C9orf72 | 7.05e-04 | 667 | 256 | 19 | GO:0060627 |
| GeneOntologyBiologicalProcess | regulation of the force of heart contraction | 7.15e-04 | 33 | 256 | 4 | GO:0002026 | |
| GeneOntologyBiologicalProcess | inclusion body assembly | 7.15e-04 | 33 | 256 | 4 | GO:0070841 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | HIP1 ERC1 SNAP47 STX1B PIK3C3 DNM1 DNM2 HAP1 SYNE1 DNM3 ERC2 C9orf72 | 7.15e-04 | 321 | 256 | 12 | GO:0099003 |
| GeneOntologyBiologicalProcess | vesicle organization | ERC1 SNAP47 LYST ANKRD27 STX1B SAMD9L PIK3C3 DNM1 DNM2 VPS37C UBR4 RFX2 DNM3 ERC2 | 7.26e-04 | 415 | 256 | 14 | GO:0016050 |
| GeneOntologyBiologicalProcess | protein-containing complex localization | HIP1 ATR SNAP47 STX1B MIOS HAP1 SYNE1 NBEA WDR19 DNM3 SPAG17 | 7.45e-04 | 278 | 256 | 11 | GO:0031503 |
| GeneOntologyBiologicalProcess | chromosome segregation | NEK6 HSPA1A HSPA1B DYNC1H1 RB1 NCAPH CIT P3H4 SPAG5 CENPQ GOLGA8B TNKS CDC6 GOLGA8A STAG3 | 7.48e-04 | 465 | 256 | 15 | GO:0007059 |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 7.55e-04 | 156 | 256 | 8 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 7.55e-04 | 156 | 256 | 8 | GO:0010927 | |
| GeneOntologyBiologicalProcess | synaptic vesicle budding | 7.70e-04 | 15 | 256 | 3 | GO:0070142 | |
| GeneOntologyBiologicalProcess | response to heat | 7.94e-04 | 121 | 256 | 7 | GO:0009408 | |
| GeneOntologyBiologicalProcess | regulation of spindle assembly | 8.02e-04 | 34 | 256 | 4 | GO:0090169 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYL4 NEK6 MYH13 SPTAN1 SARM1 ACTN4 CMYA5 KIF24 RYR2 RYR3 DNM1 BFSP2 PLS1 DYNC1H1 WDR44 DNM2 KRT15 DNAH10 KRT19 KRT81 KRT82 CEP162 KRT83 SYNE1 KRT86 GRIN2B ODF2 SPAG5 SMTN IGBP1 ANKRD1 DNM3 GOLGA8B MACF1 MYH15 MARK2 SPAG17 GOLGA8A | 2.87e-11 | 1179 | 255 | 44 | GO:0099512 |
| GeneOntologyCellularComponent | myosin II complex | 2.93e-11 | 28 | 255 | 9 | GO:0016460 | |
| GeneOntologyCellularComponent | supramolecular polymer | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYL4 NEK6 MYH13 SPTAN1 SARM1 ACTN4 CMYA5 KIF24 RYR2 RYR3 DNM1 BFSP2 PLS1 DYNC1H1 WDR44 DNM2 KRT15 DNAH10 KRT19 KRT81 KRT82 CEP162 KRT83 SYNE1 KRT86 GRIN2B ODF2 SPAG5 SMTN IGBP1 ANKRD1 DNM3 GOLGA8B MACF1 MYH15 MARK2 SPAG17 GOLGA8A | 3.58e-11 | 1187 | 255 | 44 | GO:0099081 |
| GeneOntologyCellularComponent | muscle myosin complex | 3.86e-10 | 16 | 255 | 7 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin filament | 3.97e-10 | 25 | 255 | 8 | GO:0032982 | |
| GeneOntologyCellularComponent | myofibril | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYL4 MYH13 SPTAN1 ACTN4 CMYA5 RYR2 RYR3 KRT19 SYNE1 GRIN2B ANKRD1 MYH15 | 7.71e-09 | 273 | 255 | 18 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYL4 MYH13 SPTAN1 ACTN4 CMYA5 RYR2 RYR3 KRT19 SYNE1 GRIN2B ANKRD1 MYH15 | 1.97e-08 | 290 | 255 | 18 | GO:0043292 |
| GeneOntologyCellularComponent | centrosome | NEK6 ERC1 CHD3 KIF24 STX1B DDX11 AK5 TTC12 CCDC15 TACC1 HSPA1A HSPA1B DDX11L8 DYNC1H1 DNM2 CCDC85B FAM184A DDX12P HAP1 CEP162 CNTRL UBR4 RTTN ODF2 NFS1 ECPAS SPAG5 TRIM69 CCDC88A TNKS | 2.18e-08 | 770 | 255 | 30 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule organizing center | ABCA2 NEK6 ERC1 CHD3 KIF24 STX1B DDX11 AK5 TTC12 CCDC15 TACC1 ATXN10 HSPA1A HSPA1B DDX11L8 DYNC1H1 DNM2 CCDC85B FAM184A DDX12P HAP1 CEP162 CNTRL UBR4 RTTN ODF2 NFS1 ECPAS SPAG5 SMTN TRIM69 CCDC88A TNKS | 2.89e-08 | 919 | 255 | 33 | GO:0005815 |
| GeneOntologyCellularComponent | myosin complex | 3.84e-08 | 59 | 255 | 9 | GO:0016459 | |
| GeneOntologyCellularComponent | actin cytoskeleton | FILIP1 MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 HIP1 MYL4 MYH13 SPTAN1 ACTN4 SPTBN5 TLN2 PLS1 DNM2 KRT19 HAP1 CIT SMTN CENPQ MACF1 MYH15 MARK2 PPP1R12C | 4.56e-08 | 576 | 255 | 25 | GO:0015629 |
| GeneOntologyCellularComponent | sarcomere | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYL4 SPTAN1 ACTN4 CMYA5 RYR2 RYR3 KRT19 SYNE1 GRIN2B ANKRD1 | 7.65e-08 | 249 | 255 | 16 | GO:0030017 |
| GeneOntologyCellularComponent | manchette | 9.35e-07 | 28 | 255 | 6 | GO:0002177 | |
| GeneOntologyCellularComponent | Ctf18 RFC-like complex | 4.29e-06 | 10 | 255 | 4 | GO:0031390 | |
| GeneOntologyCellularComponent | cell cortex | MYH2 HIP1 ERC1 SPTAN1 ACTN4 SPTBN5 BFSP2 PLS1 DYNC1H1 KRT19 PLA2G4C HMCN1 MACF1 ERC2 MARK2 ENO2 | 1.42e-05 | 371 | 255 | 16 | GO:0005938 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | NEK6 SARM1 KIF24 DNM1 BFSP2 PLS1 DYNC1H1 WDR44 DNM2 KRT15 DNAH10 KRT19 KRT81 KRT82 CEP162 KRT83 KRT86 ODF2 SPAG5 SMTN IGBP1 DNM3 GOLGA8B MACF1 MARK2 SPAG17 GOLGA8A | 1.59e-05 | 899 | 255 | 27 | GO:0099513 |
| GeneOntologyCellularComponent | midbody | DDX11 PIK3C3 TACC1 ATXN10 DDX11L8 DNM2 DDX12P SYNE1 CNTRL CIT SPAG5 C9orf72 | 1.93e-05 | 222 | 255 | 12 | GO:0030496 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 2.98e-05 | 129 | 255 | 9 | GO:0030863 | |
| GeneOntologyCellularComponent | spindle pole | NEK6 DDX11 DDX11L8 DDX12P CNTRL ODF2 SPAG5 GOLGA8B TNKS CDC6 GOLGA8A | 4.59e-05 | 205 | 255 | 11 | GO:0000922 |
| GeneOntologyCellularComponent | centriole | KIF24 ATXN10 HSPA1A HSPA1B DNM2 HAP1 CEP162 RTTN ODF2 CCDC88A | 5.19e-05 | 172 | 255 | 10 | GO:0005814 |
| GeneOntologyCellularComponent | cilium | ANKS6 ERC1 PKD1L1 ADGRV1 AK7 PIK3R4 SPTBN5 PIK3C3 VPS13A ATXN10 CNGA2 CNGA3 HSPD1 DNHD1 DNAH10 CEP162 CNTRL RTTN ODF2 SPAG5 WDR19 CCDC88A IFTAP IRGC SPAG17 | 1.12e-04 | 898 | 255 | 25 | GO:0005929 |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.44e-04 | 93 | 255 | 7 | GO:0030864 | |
| GeneOntologyCellularComponent | cytoplasmic region | ERC1 PIK3R4 SPTBN5 PIK3C3 HSBP1 DYNC1H1 DNHD1 DNAH10 HAP1 CEP162 CNTRL ERC2 MARK2 SPAG17 | 1.47e-04 | 360 | 255 | 14 | GO:0099568 |
| GeneOntologyCellularComponent | I band | 2.08e-04 | 166 | 255 | 9 | GO:0031674 | |
| GeneOntologyCellularComponent | microtubule | NEK6 SARM1 KIF24 DNM1 DYNC1H1 WDR44 DNM2 DNAH10 CEP162 ODF2 SPAG5 IGBP1 DNM3 GOLGA8B MACF1 SPAG17 GOLGA8A | 3.15e-04 | 533 | 255 | 17 | GO:0005874 |
| GeneOntologyCellularComponent | A band | 4.23e-04 | 52 | 255 | 5 | GO:0031672 | |
| GeneOntologyCellularComponent | Z disc | 5.45e-04 | 151 | 255 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | nuclear envelope | NUP85 ATR PTGS2 RYR2 MCM3AP PHLPP1 DYNC1H1 KPNA3 KPNA4 RTCB SYNE1 AHCTF1 PLA2G4C MTOR TNKS LTC4S C9orf72 | 5.51e-04 | 560 | 255 | 17 | GO:0005635 |
| GeneOntologyCellularComponent | spindle | NEK6 NUP85 STX1B DDX11 DDX11L8 DDX12P RB1 CEP162 CNTRL ODF2 SPAG5 GOLGA8B TNKS CDC6 GOLGA8A | 7.16e-04 | 471 | 255 | 15 | GO:0005819 |
| GeneOntologyCellularComponent | postsynapse | FILIP1 HIP1 ATR MARK1 ERC1 CYP19A1 SPTAN1 ACTN4 SNAP47 PIK3C3 UTRN DNM2 CHRNA6 HAP1 SYNE1 NBEA CAMK1 GRIN2B GRIN2D CELSR3 MTOR DNM3 MACF1 MARK2 C9orf72 | 7.28e-04 | 1018 | 255 | 25 | GO:0098794 |
| GeneOntologyCellularComponent | terminal web | 8.75e-04 | 4 | 255 | 2 | GO:1990357 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class III, type II | 8.75e-04 | 4 | 255 | 2 | GO:0034272 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class III, type I | 8.75e-04 | 4 | 255 | 2 | GO:0034271 | |
| GeneOntologyCellularComponent | centriolar satellite | 1.00e-03 | 128 | 255 | 7 | GO:0034451 | |
| GeneOntologyCellularComponent | phosphorylase kinase complex | 1.45e-03 | 5 | 255 | 2 | GO:0005964 | |
| GeneOntologyCellularComponent | nuclear pore | 1.50e-03 | 101 | 255 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.75e-03 | 141 | 255 | 7 | GO:0048786 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | PIK3R4 SPTBN5 PIK3C3 HSBP1 DYNC1H1 DNHD1 DNAH10 HAP1 CEP162 CNTRL SPAG17 | 1.86e-03 | 317 | 255 | 11 | GO:0032838 |
| GeneOntologyCellularComponent | ripoptosome | 2.15e-03 | 6 | 255 | 2 | GO:0097342 | |
| GeneOntologyCellularComponent | cell cortex region | 2.18e-03 | 45 | 255 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 2.66e-03 | 78 | 255 | 5 | GO:0001917 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NUP85 ATR CHD3 LIN52 STAT6 DDX11 NFKB1 MCM3AP MED21 HSPA1A HSPA1B DDX11L8 KPNA3 KPNA4 DDX12P ING3 EP400 RB1 SYNE1 AHCTF1 RFC2 PAAF1 GTF2A1 LIG4 CEBPZ CHD5 TNKS RPA1 CPSF3 | 2.92e-03 | 1377 | 255 | 29 | GO:0140513 |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class III | 2.99e-03 | 7 | 255 | 2 | GO:0035032 | |
| GeneOntologyCellularComponent | intracellular cyclic nucleotide activated cation channel complex | 2.99e-03 | 7 | 255 | 2 | GO:0017071 | |
| GeneOntologyCellularComponent | symbiont cell surface | 3.95e-03 | 8 | 255 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | CD95 death-inducing signaling complex | 3.95e-03 | 8 | 255 | 2 | GO:0031265 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 3.95e-03 | 8 | 255 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | axoneme | 4.01e-03 | 207 | 255 | 8 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 4.12e-03 | 208 | 255 | 8 | GO:0097014 | |
| MousePheno | abnormal manchette morphology | 4.10e-06 | 45 | 208 | 7 | MP:0009376 | |
| MousePheno | ectopic manchette | 6.82e-06 | 19 | 208 | 5 | MP:0009377 | |
| MousePheno | teratozoospermia | CYP19A1 AK7 LRGUK VPS13A RIMBP3C KPNA4 DNHD1 DNAH10 KRT19 ODF2 RFX2 RIMBP3 IFTAP CHD5 GOLGA8B IRGC SPAG17 RIMBP3B GOLGA8A | 1.12e-05 | 408 | 208 | 19 | MP:0005578 |
| MousePheno | abnormal spermatid morphology | HIP1 CYP19A1 LRGUK RIMBP3C KRT19 RFX2 RIMBP3 GTF2A1 CHD5 GOLGA8B SPAG17 RIMBP3B GOLGA8A | 2.21e-05 | 217 | 208 | 13 | MP:0006380 |
| MousePheno | abnormal cilium morphology | ANKS6 AK7 LRGUK GORAB VPS13A RIMBP3C KPNA4 DNHD1 DNAH10 KRT19 ODF2 RFX2 WDR19 RIMBP3 GOLGA8B IRGC SPAG17 RIMBP3B GOLGA8A | 2.57e-05 | 433 | 208 | 19 | MP:0013202 |
| MousePheno | abnormal sperm flagellum morphology | LRGUK VPS13A RIMBP3C KPNA4 DNHD1 DNAH10 KRT19 ODF2 RFX2 RIMBP3 GOLGA8B IRGC SPAG17 RIMBP3B GOLGA8A | 3.58e-05 | 295 | 208 | 15 | MP:0008892 |
| MousePheno | detached acrosome | 4.45e-05 | 44 | 208 | 6 | MP:0009231 | |
| MousePheno | decreased vascular permeability | 1.24e-04 | 18 | 208 | 4 | MP:0003071 | |
| MousePheno | abnormal motile cilium morphology | AK7 LRGUK VPS13A RIMBP3C KPNA4 DNHD1 DNAH10 KRT19 ODF2 RFX2 RIMBP3 GOLGA8B IRGC SPAG17 RIMBP3B GOLGA8A | 1.35e-04 | 370 | 208 | 16 | MP:0013206 |
| Domain | Myosin_N | 6.02e-12 | 15 | 253 | 8 | IPR004009 | |
| Domain | Myosin_N | 6.02e-12 | 15 | 253 | 8 | PF02736 | |
| Domain | Myosin_tail_1 | 3.95e-11 | 18 | 253 | 8 | PF01576 | |
| Domain | Myosin_tail | 3.95e-11 | 18 | 253 | 8 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 6.75e-11 | 19 | 253 | 8 | IPR027401 | |
| Domain | - | 6.75e-11 | 19 | 253 | 8 | 4.10.270.10 | |
| Domain | ARM-type_fold | HIP1 ATR SARM1 TRIP12 LYST RYR3 PIK3R4 PIK3C3 TTC12 ATXN10 UNC79 KPNA3 KPNA4 DOCK3 UBR4 RTTN NBEA ECPAS VIRMA CEBPZ MTOR STAG3 | 1.45e-09 | 339 | 253 | 22 | IPR016024 |
| Domain | P-loop_NTPase | MYH1 MYH2 MYH4 MYH6 MYH7 TRIT1 MYH8 ABCA2 MYH13 PSMC1 CHD3 KIF24 AK7 DDX11 LRGUK SAMD9L NWD2 AK5 UCKL1 DNM1 DYNC1H1 DNM2 DNHD1 ABCC1 EP400 DNAH10 RNF213 RFC2 RAB41 MMAA CHD5 DNM3 MYH15 IRGC CDC6 | 4.17e-09 | 848 | 253 | 35 | IPR027417 |
| Domain | MYOSIN_MOTOR | 3.49e-08 | 38 | 253 | 8 | PS51456 | |
| Domain | Myosin_head_motor_dom | 3.49e-08 | 38 | 253 | 8 | IPR001609 | |
| Domain | Myosin_head | 3.49e-08 | 38 | 253 | 8 | PF00063 | |
| Domain | MYSc | 3.49e-08 | 38 | 253 | 8 | SM00242 | |
| Domain | Spectrin | 4.85e-07 | 23 | 253 | 6 | PF00435 | |
| Domain | ACTININ_2 | 4.85e-07 | 23 | 253 | 6 | PS00020 | |
| Domain | ACTININ_1 | 4.85e-07 | 23 | 253 | 6 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 4.85e-07 | 23 | 253 | 6 | IPR001589 | |
| Domain | Spectrin_repeat | 2.13e-06 | 29 | 253 | 6 | IPR002017 | |
| Domain | CH | 2.63e-06 | 65 | 253 | 8 | SM00033 | |
| Domain | SPEC | 3.93e-06 | 32 | 253 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.93e-06 | 32 | 253 | 6 | IPR018159 | |
| Domain | CH | 4.64e-06 | 70 | 253 | 8 | PF00307 | |
| Domain | - | 5.17e-06 | 71 | 253 | 8 | 1.10.418.10 | |
| Domain | CH | 6.38e-06 | 73 | 253 | 8 | PS50021 | |
| Domain | CH-domain | 7.83e-06 | 75 | 253 | 8 | IPR001715 | |
| Domain | MARK/par1 | 9.73e-06 | 4 | 253 | 3 | IPR033624 | |
| Domain | - | TRIT1 ABCA2 PSMC1 CHD3 AK7 DDX11 LRGUK SAMD9L NWD2 AK5 UCKL1 DNM1 DYNC1H1 DNM2 DNHD1 ABCC1 EP400 DNAH10 RNF213 RFC2 RAB41 MMAA CHD5 DNM3 IRGC CDC6 | 1.05e-05 | 746 | 253 | 26 | 3.40.50.300 |
| Domain | KA1_dom | 2.41e-05 | 5 | 253 | 3 | IPR001772 | |
| Domain | KA1 | 2.41e-05 | 5 | 253 | 3 | PS50032 | |
| Domain | - | 2.41e-05 | 5 | 253 | 3 | 3.30.310.80 | |
| Domain | KA1 | 2.41e-05 | 5 | 253 | 3 | PF02149 | |
| Domain | IQ | 3.83e-05 | 93 | 253 | 8 | PS50096 | |
| Domain | Dynamin_M | 4.77e-05 | 6 | 253 | 3 | PF01031 | |
| Domain | GED | 4.77e-05 | 6 | 253 | 3 | PS51388 | |
| Domain | GED | 4.77e-05 | 6 | 253 | 3 | IPR003130 | |
| Domain | Dynamin_central | 4.77e-05 | 6 | 253 | 3 | IPR000375 | |
| Domain | GED | 4.77e-05 | 6 | 253 | 3 | SM00302 | |
| Domain | GED_dom | 4.77e-05 | 6 | 253 | 3 | IPR020850 | |
| Domain | Dynamin_GTPase_CS | 4.77e-05 | 6 | 253 | 3 | IPR019762 | |
| Domain | GED | 4.77e-05 | 6 | 253 | 3 | PF02212 | |
| Domain | Filament | 4.90e-05 | 71 | 253 | 7 | SM01391 | |
| Domain | - | ATR SARM1 TRIP12 PIK3R4 TTC12 ATXN10 KPNA3 KPNA4 RTTN ECPAS MTOR STAG3 | 5.28e-05 | 222 | 253 | 12 | 1.25.10.10 |
| Domain | IF | 5.36e-05 | 72 | 253 | 7 | PS00226 | |
| Domain | Filament | 5.86e-05 | 73 | 253 | 7 | PF00038 | |
| Domain | - | MYL4 SPTAN1 EFCAB13 ACTN4 RYR2 RYR3 STAT6 CAPN8 NECAB1 UTRN PLS1 EFHD1 MACF1 | 6.01e-05 | 261 | 253 | 13 | 1.10.238.10 |
| Domain | IF | 7.60e-05 | 76 | 253 | 7 | IPR001664 | |
| Domain | DYNc | 8.26e-05 | 7 | 253 | 3 | SM00053 | |
| Domain | KA1/Ssp2_C | 8.26e-05 | 7 | 253 | 3 | IPR028375 | |
| Domain | G_DYNAMIN_1 | 8.26e-05 | 7 | 253 | 3 | PS00410 | |
| Domain | ARM-like | ATR SARM1 TRIP12 PIK3R4 TTC12 ATXN10 KPNA3 KPNA4 RTTN NBEA ECPAS MTOR STAG3 | 8.48e-05 | 270 | 253 | 13 | IPR011989 |
| Domain | IQ | 1.14e-04 | 81 | 253 | 7 | SM00015 | |
| Domain | AAA+_ATPase | 1.55e-04 | 144 | 253 | 9 | IPR003593 | |
| Domain | AAA | 1.55e-04 | 144 | 253 | 9 | SM00382 | |
| Domain | EF-hand-dom_pair | MYL4 SPTAN1 EFCAB13 ACTN4 RYR2 RYR3 STAT6 CAPN8 NECAB1 UTRN PLS1 EFHD1 MACF1 | 1.56e-04 | 287 | 253 | 13 | IPR011992 |
| Domain | ELKS/CAST | 1.83e-04 | 2 | 253 | 2 | IPR019323 | |
| Domain | Cast | 1.83e-04 | 2 | 253 | 2 | PF10174 | |
| Domain | Intermediate_filament_CS | 2.07e-04 | 63 | 253 | 6 | IPR018039 | |
| Domain | IQ_motif_EF-hand-BS | 2.21e-04 | 90 | 253 | 7 | IPR000048 | |
| Domain | Keratin_2_head | 2.82e-04 | 24 | 253 | 4 | IPR032444 | |
| Domain | Keratin_2_head | 2.82e-04 | 24 | 253 | 4 | PF16208 | |
| Domain | EF_HAND_2 | MYL4 SPTAN1 EFCAB13 ACTN4 RYR2 RYR3 CAPN8 NECAB1 PLS1 EFHD1 MACF1 | 3.26e-04 | 231 | 253 | 11 | PS50222 |
| Domain | Keratin_II | 3.89e-04 | 26 | 253 | 4 | IPR003054 | |
| Domain | IQ | 3.99e-04 | 71 | 253 | 6 | PF00612 | |
| Domain | Glyco_hydro_15/PHK | 5.43e-04 | 3 | 253 | 2 | IPR011613 | |
| Domain | CHD_N | 5.43e-04 | 3 | 253 | 2 | IPR012958 | |
| Domain | CHD_C2 | 5.43e-04 | 3 | 253 | 2 | IPR012957 | |
| Domain | Glyco_hydro_15 | 5.43e-04 | 3 | 253 | 2 | PF00723 | |
| Domain | RyR | 5.43e-04 | 3 | 253 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 5.43e-04 | 3 | 253 | 2 | PF06459 | |
| Domain | DUF1087 | 5.43e-04 | 3 | 253 | 2 | PF06465 | |
| Domain | DUF1086 | 5.43e-04 | 3 | 253 | 2 | PF06461 | |
| Domain | Ryan_recept | 5.43e-04 | 3 | 253 | 2 | IPR013333 | |
| Domain | Ryanodine_rcpt | 5.43e-04 | 3 | 253 | 2 | IPR003032 | |
| Domain | PHK_A/B_su | 5.43e-04 | 3 | 253 | 2 | IPR008734 | |
| Domain | CHDCT2 | 5.43e-04 | 3 | 253 | 2 | PF08074 | |
| Domain | CHDNT | 5.43e-04 | 3 | 253 | 2 | PF08073 | |
| Domain | Ryanrecept_TM4-6 | 5.43e-04 | 3 | 253 | 2 | IPR009460 | |
| Domain | DUF1086 | 5.43e-04 | 3 | 253 | 2 | IPR009462 | |
| Domain | DUF1087 | 5.43e-04 | 3 | 253 | 2 | IPR009463 | |
| Domain | DUF1087 | 5.43e-04 | 3 | 253 | 2 | SM01147 | |
| Domain | DUF1086 | 5.43e-04 | 3 | 253 | 2 | SM01146 | |
| Domain | PH_dom-like | NET1 LYST TIAM2 SPTBN5 OSBPL1A PHLPP1 TLN2 DNM1 DNM2 PHLDB3 ARHGEF18 ECT2L NBEA CIT DNM3 | 7.40e-04 | 426 | 253 | 15 | IPR011993 |
| Domain | G_DYNAMIN_dom | 8.01e-04 | 14 | 253 | 3 | IPR030381 | |
| Domain | MT | 8.01e-04 | 14 | 253 | 3 | PF12777 | |
| Domain | G_DYNAMIN_2 | 8.01e-04 | 14 | 253 | 3 | PS51718 | |
| Domain | Dynein_HC_stalk | 8.01e-04 | 14 | 253 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 8.01e-04 | 14 | 253 | 3 | IPR013602 | |
| Domain | DHC_N2 | 8.01e-04 | 14 | 253 | 3 | PF08393 | |
| Domain | Dynamin_GTPase | 9.91e-04 | 15 | 253 | 3 | IPR001401 | |
| Domain | Dynamin_SF | 9.91e-04 | 15 | 253 | 3 | IPR022812 | |
| Domain | Dynamin_N | 9.91e-04 | 15 | 253 | 3 | PF00350 | |
| Domain | DHC_fam | 9.91e-04 | 15 | 253 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 9.91e-04 | 15 | 253 | 3 | PF03028 | |
| Domain | PI3/4_kinase_CS | 9.91e-04 | 15 | 253 | 3 | IPR018936 | |
| Domain | Dynein_heavy_dom | 9.91e-04 | 15 | 253 | 3 | IPR004273 | |
| Domain | CLZ | 1.08e-03 | 4 | 253 | 2 | PF16526 | |
| Domain | ILWEQ | 1.08e-03 | 4 | 253 | 2 | PD011820 | |
| Domain | I_LWEQ | 1.08e-03 | 4 | 253 | 2 | PF01608 | |
| Domain | I_LWEQ | 1.08e-03 | 4 | 253 | 2 | PS50945 | |
| Domain | CLZ_dom | 1.08e-03 | 4 | 253 | 2 | IPR032406 | |
| Domain | ILWEQ_dom | 1.08e-03 | 4 | 253 | 2 | IPR002558 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 5.07e-06 | 70 | 194 | 8 | M12294 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.41e-05 | 132 | 194 | 10 | M11355 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS | 4.98e-05 | 6 | 194 | 3 | M27890 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS | 4.98e-05 | 6 | 194 | 3 | MM15615 | |
| Pathway | REACTOME_HSF1_ACTIVATION | 5.95e-05 | 31 | 194 | 5 | M27252 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 7.54e-05 | 101 | 194 | 8 | M27253 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 1.15e-04 | 19 | 194 | 4 | M27889 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 1.22e-04 | 170 | 194 | 10 | M7494 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.55e-04 | 59 | 194 | 6 | M27140 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.63e-04 | 38 | 194 | 5 | M27255 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 2.09e-04 | 22 | 194 | 4 | MM15614 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 2.51e-04 | 23 | 194 | 4 | MM14953 | |
| Pathway | BIOCARTA_SKP2E2F_PATHWAY | 2.87e-04 | 10 | 194 | 3 | MM1384 | |
| Pathway | BIOCARTA_SKP2E2F_PATHWAY | 2.87e-04 | 10 | 194 | 3 | M6031 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 2.94e-04 | 155 | 194 | 9 | MM14665 | |
| Pathway | WP_OXYLIPINS_PATHWAYS | 2.98e-04 | 24 | 194 | 4 | MM17249 | |
| Pubmed | KDM5B ABCA2 UBE4B ERC1 SPTAN1 PSMC1 ACTN4 PFDN2 CMYA5 TRIP12 RYR3 STAT6 PIK3R4 GDAP1L1 TTC7B NECAB1 OSBPL1A USP7 CCDC15 TLN2 ATXN10 DNM1 HSPA1A HSPA1B UTRN DYNC1H1 DNM2 KPNA3 KPNA4 DOCK3 KRT83 SYNE1 UBR4 NBEA CAMK1 GRIN2B ODF2 CIT WDR19 CELSR3 NEMF DNM3 MACF1 ERC2 TNKS HARS1 | 1.50e-18 | 1285 | 263 | 46 | 35914814 | |
| Pubmed | MYH6 MARK1 MARK3 ERC1 SPTAN1 ETF1 PSMC1 ACTN4 CHD3 SNAP47 PTGS2 STX1B PIK3R4 GRAMD1B NWD2 TTC7B USP7 MIOS TLN2 C4A C4B DNM1 HSPA1A HSPA1B UTRN DYNC1H1 DNM2 KPNA3 HSPD1 PITPNM2 RTCB WDR7 KRT19 SYNE1 NBEA GRIN2B CIT VIRMA MACF1 ERC2 MARK2 ENO2 ALDH7A1 PPP1R12C | 2.29e-15 | 1431 | 263 | 44 | 37142655 | |
| Pubmed | 1.23e-12 | 7 | 263 | 6 | 35210422 | ||
| Pubmed | 1.23e-12 | 7 | 263 | 6 | 16819597 | ||
| Pubmed | 4.88e-12 | 8 | 263 | 6 | 3864153 | ||
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 2.38e-11 | 5 | 263 | 5 | 12919077 | |
| Pubmed | ERC1 SPTAN1 PSMC1 ACTN4 PFDN2 PHKA1 PTPRC TTC7B NFKB1 VPS13A USP7 MIOS PHLPP1 ATXN10 UTRN KPNA3 KPNA4 ABCC1 CEP162 RNF213 NBEA CPD ODF2 PAAF1 IGBP1 CCDC88A CEBPZ CRYBG3 HARS1 RPA1 CPSF3 PPP1R12C | 2.62e-11 | 1049 | 263 | 32 | 27880917 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | NUP85 UBE4B SPTAN1 ETF1 PSMC1 ACTN4 PFDN2 COG3 CMYA5 PGGT1B STAT6 EHBP1L1 USP7 ATXN10 DNM1 HSPA1A PLS1 DYNC1H1 WDR44 KPNA3 KPNA4 HSPD1 CUL1 LIMD1 RTCB UBR4 LAMB2 RFC2 ECPAS PAAF1 NCAPH GTF2A1 MTOR MACF1 HARS1 RPA1 ENO2 ALDH7A1 | 2.98e-11 | 1455 | 263 | 38 | 22863883 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | UBE4B SPTAN1 ACTN4 AK5 TLN2 DNM1 DYNC1H1 PITPNM2 WDR7 SYNE1 ARHGEF18 NBEA GRIN2B GRIN2D CIT MTOR MACF1 | 6.34e-11 | 281 | 263 | 17 | 28706196 |
| Pubmed | SPTAN1 SARM1 ACTN4 RYR3 GVINP1 MIOS HSPA1B DYNC1H1 KPNA4 HSPD1 RB1 KRT19 KRT81 KRT83 KRT86 RFC2 ZBTB10 | 7.49e-11 | 284 | 263 | 17 | 29459677 | |
| Pubmed | ATP5F1D MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 NUP85 MYH13 ERC1 SPTAN1 ACTN4 CHD3 NDUFAB1 TRIP12 LYST RYR2 DDX11 VPS13A PLS1 KPNA4 HSPD1 KRT15 KRT19 SYNE1 CNTRL UBR4 ODF2 NCAPH LIG4 GTF3C1 CEBPZ CHD5 MACF1 ERC2 MYH15 SPAG17 | 9.20e-11 | 1442 | 263 | 37 | 35575683 | |
| Pubmed | 1.42e-10 | 6 | 263 | 5 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.42e-10 | 6 | 263 | 5 | 10077619 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 1.42e-10 | 6 | 263 | 5 | 10588881 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 2.90e-10 | 13 | 263 | 6 | 8404542 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH1 MYH2 MYH6 MYH7 MYH8 NEK6 MYH13 ATR MARK1 MARK3 LYST PIK3R4 GRAMD1B PHKA1 PHKA2 USP7 HSPA1A HSPA1B UTRN DNM2 CUL1 NFS1 SKP2 GTF3C1 TBK1 DNM3 MYH15 MARK2 | 4.13e-10 | 910 | 263 | 28 | 36736316 |
| Pubmed | USP7 controls NGN3 stability and pancreatic endocrine lineage development. | 5.43e-10 | 58 | 263 | 9 | 37117185 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBE4B SPTAN1 PSMC1 ACTN4 TRIP12 ANKRD27 PIK3R4 MCM3AP USP7 TIMM44 UTRN DYNC1H1 KPNA3 HSPD1 CUL1 PHLDB3 EP400 RTCB RB1 AHCTF1 UBR4 PPIL4 RFC2 NCAPH SMTN GTF3C1 CEBPZ RTCA ZBTB10 MACF1 KDM2A RPA1 CPSF3 ALDH7A1 | 9.81e-10 | 1353 | 263 | 34 | 29467282 |
| Pubmed | ATP5F1D MYH2 HIP1 NUP85 MARK3 SPTAN1 PSMC1 COG3 LMBRD2 SNAP47 GRAMD1B AARS2 NFKB1 USP7 TIMM44 DYNC1H1 CCDC85B KPNA3 HSPD1 CUL1 ABCC1 RTCB UBR4 RNF213 RFC2 ECPAS NCAPH SKP2 SPAG5 SMTN ANKRD13A GTF3C1 CEBPZ MTOR RPA1 | 1.29e-09 | 1440 | 263 | 35 | 30833792 | |
| Pubmed | ERC1 SPTAN1 ETF1 MIOS TLN2 DNM1 UNC79 DYNC1H1 DNM2 WDR7 SYNE1 UBR4 ARHGEF18 NBEA GRIN2B GRIN2D CIT VIRMA CCDC88A MTOR TBK1 DNM3 GOLGA8B MACF1 ERC2 TNKS RPA1 GOLGA8A | 1.45e-09 | 963 | 263 | 28 | 28671696 | |
| Pubmed | SPTAN1 ACTN4 DNM1 HSPA1B DYNC1H1 DNM2 HSPD1 KRT15 KRT19 KRT81 KRT82 KRT83 KRT86 UBR4 DNM3 | 2.26e-09 | 266 | 263 | 15 | 19380743 | |
| Pubmed | 3.20e-09 | 4 | 263 | 4 | 10388558 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH2 KDM5B MYH4 NUP85 NET1 MARK1 MARK3 ETF1 PSMC1 PFDN2 TRIP12 USP7 MIOS PHLPP1 UTRN KPNA3 CUL1 P4HA2 KRT19 KRT81 PPIL4 RFC2 PAAF1 SKP2 TBK1 RTCA TNKS MARK2 | 3.68e-09 | 1005 | 263 | 28 | 19615732 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYH13 ERC1 SPTAN1 ETF1 PSMC1 ACTN4 PFDN2 CHD3 NDUFAB1 TLN2 HSPA1A HSPA1B UTRN DYNC1H1 DNM2 HSPD1 CUL1 RTCB RFC2 NCAPH CIT DNM3 MACF1 HARS1 ENO2 | 8.61e-09 | 847 | 263 | 25 | 35235311 |
| Pubmed | 1.06e-08 | 11 | 263 | 5 | 8136524 | ||
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 1.06e-08 | 11 | 263 | 5 | 29168801 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYH7 NUP85 TRIP12 PHKA2 AARS2 NFKB1 CCDC15 DYNC1H1 HSPD1 CUL1 ING3 EP400 RB1 UBR4 ECPAS NCAPH RFX2 SKP2 P3H4 LIG4 RNASEL GTF3C1 RTCA ZBTB10 KDM2A | 1.08e-08 | 857 | 263 | 25 | 25609649 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATP8B4 ATR SPTAN1 ETF1 PSMC1 ACTN4 CMYA5 PIK3R4 USP7 TLN2 ATXN10 TIMM44 HSPA1A DYNC1H1 HSPD1 CUL1 DNHD1 DNAH10 RTCB SYNE1 UBR4 PPIL4 RFC2 ECPAS NCAPH GTF3C1 CEBPZ MTOR TBK1 NEMF HARS1 RPA1 CPSF3 | 1.29e-08 | 1425 | 263 | 33 | 30948266 |
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | APOBR HSPA1A HSPA1B DYNC1H1 LIMD1 WDR7 UBR4 VWA5A TBK1 MACF1 CRYBG3 | 1.34e-08 | 143 | 263 | 11 | 30397336 |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.59e-08 | 5 | 263 | 4 | 3829126 | |
| Pubmed | 1.59e-08 | 5 | 263 | 4 | 6196357 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYH7 ERC1 SPTAN1 PSMC1 ACTN4 PFDN2 PHKA1 PHKA2 USP7 HSBP1 ATXN10 HSPA1A DYNC1H1 DNM2 KPNA3 KPNA4 HSPD1 RTCB UBR4 RFC2 ECPAS NCAPH GTF3C1 NEMF MACF1 HARS1 RPA1 ENO2 ALDH7A1 | 1.68e-08 | 1149 | 263 | 29 | 35446349 |
| Pubmed | NET1 MARK1 ACTN4 CHD3 TRIP12 PGGT1B PTGS2 TIAM2 STAT6 PTPRC UTRN SPTY2D1 PLXNB1 DNM2 CCDC85B KPNA3 P4HA2 CEP162 AHCTF1 CNTRL SLFN12 ARHGEF18 SPAG5 SMTN TYW1B ZBTB10 MACF1 RPA1 | 1.86e-08 | 1084 | 263 | 28 | 11544199 | |
| Pubmed | SPTAN1 SPTBN5 HSPA1A HSPD1 DNHD1 DNAH10 KRT82 SYNE1 RTTN RNF213 CELSR3 CEBPZ | 2.25e-08 | 187 | 263 | 12 | 26460568 | |
| Pubmed | MYH7 NUP85 ERC1 ADGRV1 HSPA1B PLS1 HSPD1 CUL1 SYNE1 HMCN1 MACF1 | 2.54e-08 | 152 | 263 | 11 | 34299191 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HIP1 ABCA2 ANKS6 NUP85 UBE4B LYST TNFRSF21 TIAM2 SLC38A10 EHBP1L1 UCKL1 MCM3AP USP7 TLN2 DYNC1H1 DOCK3 PITPNM2 PHLDB3 EP400 UBR4 RTTN LAMB2 GRIN2D CIT CELSR3 MTOR CHD5 NPRL3 | 2.79e-08 | 1105 | 263 | 28 | 35748872 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYH13 SPTAN1 ACTN4 AARS2 ATXN10 HSPA1A HSPA1B DYNC1H1 DNM2 HSPD1 UBR4 RFC2 NCAPH ANKRD13A MTOR | 2.86e-08 | 647 | 263 | 21 | 26618866 |
| Pubmed | NUP85 ATR CHD3 LMBRD2 ANKRD27 PIK3R4 PHKA2 C4A C4B DNM1 DDX11L8 PLXNB1 DNM2 SPAG5 LIG4 CCDC88A GTF3C1 TBK1 NEMF CRYBG3 MARK2 | 3.09e-08 | 650 | 263 | 21 | 38777146 | |
| Pubmed | MYH1 MYH2 MYH4 MYH6 MYH8 ACTN4 PFDN2 CHD3 CMYA5 C4A C4B HSPA1A UTRN DYNC1H1 HSPD1 KRT19 SYNE1 UBR4 RNF213 HMCN1 TBK1 MACF1 HARS1 RPA1 | 3.49e-08 | 844 | 263 | 24 | 25963833 | |
| Pubmed | ATP5F1D MYH1 MYH6 MYH8 MYL4 PSMC1 ACTN4 CMYA5 RYR2 DNAJC28 HSPA1A HSPA1B DYNC1H1 HSPD1 MMAA | 4.21e-08 | 331 | 263 | 15 | 29199018 | |
| Pubmed | 4.51e-08 | 14 | 263 | 5 | 24938781 | ||
| Pubmed | 4.51e-08 | 14 | 263 | 5 | 27184118 | ||
| Pubmed | MYH2 MYH4 NET1 ERC1 PSMC1 PIK3R4 PIK3C3 USP7 HSBP1 UTRN DNM2 ECPAS GTF3C1 MTOR TBK1 RPA1 ALDH7A1 | 4.84e-08 | 437 | 263 | 17 | 20562859 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH2 MYH4 MYH7 NEK6 MARK3 ERC1 PSMC1 PFDN2 CMYA5 PIK3R4 CFLAR PIK3C3 USP7 ATXN10 UNC79 DYNC1H1 KPNA3 KPNA4 CUL1 KRT82 CEP162 UBR4 ECPAS PAAF1 GTF2A1 LIG4 EFHD1 RTCA ELF3 MARK2 | 5.17e-08 | 1284 | 263 | 30 | 17353931 |
| Pubmed | ATP5F1D MARK1 ERC1 SPTAN1 PSMC1 ACTN4 SNAP47 STX1B RYR2 GRAMD1B USP7 TLN2 HSBP1 TACC1 TIMM44 HSPA1B HSPD1 DOCK3 PITPNM2 VPS37C UBR4 NBEA GRIN2B NFS1 CIT CCDC88A MACF1 CRYBG3 | 5.24e-08 | 1139 | 263 | 28 | 36417873 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH1 MYH4 PSMC1 TRIP12 SLC38A10 SAMD9L MCM3AP VPS13A UTRN PLS1 DYNC1H1 HSPD1 RB1 KRT19 UBR4 RNF213 NBEA ECPAS GTF3C1 TBK1 TLR3 RPA1 | 5.63e-08 | 736 | 263 | 22 | 29676528 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ABCA2 ERC1 SPTAN1 ETF1 ACTN4 COG3 USP7 HSPA1B UNC79 UTRN DYNC1H1 DNM2 HSPD1 CUL1 RTCB SYNE1 CNTRL UBR4 ECPAS SPAG5 MACF1 HARS1 SPAG17 | 6.55e-08 | 807 | 263 | 23 | 30575818 |
| Pubmed | FILIP1 MYH2 NUP85 SPTAN1 CHD3 TRIP12 HSPD1 RNF213 RFC2 LIG4 GTF3C1 CEBPZ KDM2A | 6.99e-08 | 250 | 263 | 13 | 33536335 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | PFDN2 AARS2 USP7 TIMM44 PLS1 KPNA3 KPNA4 ING3 EP400 RB1 SKP2 IFTAP KDM2A TNKS C9orf72 RPA1 | 7.74e-08 | 398 | 263 | 16 | 35016035 |
| Pubmed | MYH7 NUP85 ERC1 SPTAN1 PSMC1 TIAM2 USP7 HSPA1A DYNC1H1 KPNA4 HSPD1 ABCC1 ING3 EP400 RTCB WDR7 SYNE1 CNTRL CASP10 ECPAS NCAPH STAG3 | 8.56e-08 | 754 | 263 | 22 | 35906200 | |
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 9.71e-08 | 16 | 263 | 5 | 19922871 | |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 1.10e-07 | 7 | 263 | 4 | 29758057 | |
| Pubmed | 1.11e-07 | 31 | 263 | 6 | 21985497 | ||
| Pubmed | ERC1 SPTAN1 EHBP1L1 AARS2 TIMM44 HSPA1B UTRN DYNC1H1 DNM2 HSPD1 KRT15 RTCB MACF1 KDM2A RPA1 | 1.26e-07 | 360 | 263 | 15 | 33111431 | |
| Pubmed | IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. | 1.37e-07 | 17 | 263 | 5 | 22351927 | |
| Pubmed | CHD3 TRIP12 ANKRD27 RYR2 PHKA2 PTPRC MCM3AP UTRN DYNC1H1 DNM2 LIMD1 KRT81 UBR4 PPIL4 LAMB2 ANKRD13A TRIM69 MACF1 KDM2A | 1.55e-07 | 591 | 263 | 19 | 15231748 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ERC1 PKD1L1 PSMC1 ACTN4 PFDN2 NFKB1 TIMM44 FHIP1A DYNC1H1 HSPD1 FAM184A LIMD1 KRT19 CEP162 CNTRL CPD ODF2 ECPAS SPAG5 RIMBP3 CCDC88A TBK1 ALDH7A1 | 1.75e-07 | 853 | 263 | 23 | 28718761 |
| Pubmed | MYH1 MYH7 SPTAN1 PSMC1 ACTN4 PFDN2 CHD3 CAPN8 HSPA1A UTRN DYNC1H1 KPNA4 CUL1 RTCB CAMK1 MTOR MACF1 ENO2 | 1.85e-07 | 538 | 263 | 18 | 28524877 | |
| Pubmed | MARK3 ERC1 SPTAN1 GRAMD1B AK5 DYNC1H1 WDR7 ARHGEF18 CCDC88A MARK2 | 1.97e-07 | 147 | 263 | 10 | 16959763 | |
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 2.18e-07 | 8 | 263 | 4 | 14667415 | |
| Pubmed | 2.18e-07 | 8 | 263 | 4 | 26993635 | ||
| Pubmed | SPTAN1 ACTN4 MCM3AP C4A HSPA1A WDR44 KPNA4 HSPD1 KRT15 KRT19 SYNE1 CNTRL LAMB2 GTF2A1 CCDC88A MACF1 KDM2A | 2.19e-07 | 486 | 263 | 17 | 20936779 | |
| Pubmed | SPTAN1 TIAM2 UTRN DYNC1H1 SYNE1 NBEA CCDC88A MACF1 TNKS HARS1 | 2.54e-07 | 151 | 263 | 10 | 17043677 | |
| Pubmed | ATP5F1D MYH7 MYH8 ESRRG ACTN4 CMYA5 ATXN10 HSPA1B UTRN DNM2 SYNE1 IGBP1 TBK1 ANKRD1 MACF1 KDM2A TNKS | 3.00e-07 | 497 | 263 | 17 | 23414517 | |
| Pubmed | UBASH3A Regulates the Synthesis and Dynamics of TCR-CD3 Complexes. | 3.36e-07 | 20 | 263 | 5 | 31659016 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | MARK3 SPTAN1 RYR2 MCM3AP UTRN SYNE1 ARHGEF18 VIRMA GTF2A1 MACF1 TNKS | 3.55e-07 | 197 | 263 | 11 | 20811636 |
| Pubmed | 3.91e-07 | 9 | 263 | 4 | 31960486 | ||
| Pubmed | 4.28e-07 | 3 | 263 | 3 | 12511974 | ||
| Pubmed | 4.28e-07 | 3 | 263 | 3 | 17611414 | ||
| Pubmed | Novel KRT83 and KRT86 mutations associated with monilethrix. | 4.28e-07 | 3 | 263 | 3 | 25557232 | |
| Pubmed | 4.28e-07 | 3 | 263 | 3 | 21854770 | ||
| Pubmed | 4.28e-07 | 3 | 263 | 3 | 21470888 | ||
| Pubmed | Structure and site of expression of a murine type II hair keratin. | 4.28e-07 | 3 | 263 | 3 | 1372089 | |
| Pubmed | 4.28e-07 | 3 | 263 | 3 | 24273169 | ||
| Pubmed | 4.28e-07 | 3 | 263 | 3 | 1712823 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 4.28e-07 | 3 | 263 | 3 | 26059207 | |
| Pubmed | 4.28e-07 | 3 | 263 | 3 | 15203187 | ||
| Pubmed | 4.28e-07 | 3 | 263 | 3 | 12383797 | ||
| Pubmed | Structural and developmental analysis of two linked myosin heavy chain genes. | 4.28e-07 | 3 | 263 | 3 | 1371481 | |
| Pubmed | Developmental expression of the dynamin family of mechanoenzymes in the mouse epididymis. | 4.28e-07 | 3 | 263 | 3 | 28395327 | |
| Pubmed | 4.28e-07 | 3 | 263 | 3 | 12517701 | ||
| Pubmed | Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. | 4.28e-07 | 3 | 263 | 3 | 24046449 | |
| Pubmed | 4.28e-07 | 3 | 263 | 3 | 20643136 | ||
| Pubmed | NUP85 SPTAN1 ETF1 PSMC1 ACTN4 AARS2 USP7 ATXN10 TIMM44 HSPA1B DYNC1H1 DNM2 HSPD1 CUL1 UBR4 ECPAS MTOR RPA1 CPSF3 | 4.93e-07 | 638 | 263 | 19 | 33239621 | |
| Pubmed | 5.64e-07 | 22 | 263 | 5 | 24301466 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ATR SPTAN1 PSMC1 CHD3 TRIP12 PIK3R4 TLN2 DYNC1H1 DNM2 HSPD1 CUL1 RTCB RFC2 NCAPH MACF1 MARK2 RPA1 CPSF3 | 5.78e-07 | 582 | 263 | 18 | 20467437 |
| Pubmed | The expression of myosin genes in developing skeletal muscle in the mouse embryo. | 6.48e-07 | 10 | 263 | 4 | 2211821 | |
| Pubmed | 6.48e-07 | 10 | 263 | 4 | 10679931 | ||
| Pubmed | 6.48e-07 | 10 | 263 | 4 | 23746204 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | NUP85 ATR ACTN4 CHD3 AARS2 ATXN10 UTRN SPTY2D1 KPNA4 KRT15 EP400 ARHGEF18 GTF3C1 DNM3 MARK2 | 6.55e-07 | 410 | 263 | 15 | 26949251 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KDM5B NET1 MARK3 ERC1 SPTAN1 TRIP12 LYST ANKRD27 PIK3R4 PIK3C3 UTRN LIMD1 RTCB KRT19 CEP162 VIRMA CCDC88A MTOR MACF1 CRYBG3 MARK2 PPP1R12C | 8.03e-07 | 861 | 263 | 22 | 36931259 |
| Pubmed | 1.01e-06 | 11 | 263 | 4 | 18310078 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 1.01e-06 | 11 | 263 | 4 | 16024798 | |
| Pubmed | CCDC134 ABCA2 NUP85 PSMC1 LMBRD2 APOBR ANKRD27 PIK3R4 GRAMD1B EHBP1L1 PTPRC PIK3C3 ATXN10 DYNC1H1 HSPD1 ABCC1 CNTRL UBR4 RNF213 CPD ECPAS NCAPH CIT GTF3C1 MTOR CHD5 | 1.05e-06 | 1168 | 263 | 26 | 19946888 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NUP85 PSMC1 ACTN4 CHD3 TRIP12 AARS2 ATXN10 UTRN DYNC1H1 HSPD1 EP400 RTCB KRT82 SYNE1 KRT86 LAMB2 RFC2 CIT GTF3C1 CEBPZ TBK1 MACF1 MARK2 RPA1 | 1.15e-06 | 1024 | 263 | 24 | 24711643 |
| Pubmed | ATP5F1D HIP1 NET1 MARK3 PSMC1 GORAB USP7 MIOS UTRN FHIP1A SPTY2D1 KPNA3 KPNA4 FAM184A ING3 EP400 RTCB SYNE1 AHCTF1 LAMB2 ECT2L ODF2 RFC2 CIT VIRMA CEBPZ EFHD1 MACF1 MARK2 PPP1R12C | 1.31e-06 | 1497 | 263 | 30 | 31527615 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MARK1 MARK3 ERC1 SARM1 LMBRD2 USP7 HSBP1 SPTY2D1 KPNA3 KPNA4 ABCC1 CNTRL ECPAS CIT CEBPZ MTOR TBK1 MARK2 CPSF3 ALDH7A1 | 1.47e-06 | 754 | 263 | 20 | 33060197 |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 1.48e-06 | 183 | 263 | 10 | 31932471 | |
| Pubmed | 1.51e-06 | 12 | 263 | 4 | 23569248 | ||
| Pubmed | Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain. | 1.51e-06 | 12 | 263 | 4 | 10692104 | |
| Interaction | KCTD13 interactions | MYH6 MARK1 MARK3 ERC1 SPTAN1 ETF1 PSMC1 ACTN4 PFDN2 CHD3 SNAP47 PTGS2 STX1B PIK3R4 GRAMD1B NWD2 TTC7B USP7 MIOS TLN2 DNM1 HSPA1A UTRN DYNC1H1 DNM2 KPNA3 HSPD1 PITPNM2 RTCB WDR7 KRT19 SYNE1 NBEA GRIN2B CIT VIRMA MACF1 ERC2 MARK2 ENO2 ALDH7A1 PPP1R12C | 2.03e-07 | 1394 | 259 | 42 | int:KCTD13 |
| Interaction | CDK3 interactions | 2.56e-07 | 114 | 259 | 11 | int:CDK3 | |
| Interaction | HDAC1 interactions | MYH1 MYH2 KDM5B MYH4 MYH7 MYH8 ATR ERC1 SPTAN1 PSMC1 PFDN2 CHD3 NFKB1 USP7 PHLPP1 HSPA1A HSPA1B UTRN KPNA3 KPNA4 HSPD1 EP400 RTCB RB1 UBR4 ECPAS PAAF1 NCAPH CIT VIRMA SPAG5 TBK1 CHD5 CRYBG3 C9orf72 RPA1 | 2.86e-07 | 1108 | 259 | 36 | int:HDAC1 |
| Interaction | GYPA interactions | NEK6 ATR SARM1 PIK3C3 UCKL1 DNM1 DNM2 RB1 CAMK1 ECPAS MTOR NEMF DNM3 | 4.19e-07 | 174 | 259 | 13 | int:GYPA |
| Interaction | PCNT interactions | SPTAN1 CHD3 NECAB1 DNM1 UTRN DNM2 KPNA3 FAM184A KRT19 CEP162 SYNE1 CNTRL VIRMA DNM3 MACF1 | 5.71e-07 | 241 | 259 | 15 | int:PCNT |
| Interaction | DISC1 interactions | MYH7 SPTAN1 TIAM2 AARS2 NECAB1 USP7 BFSP2 UTRN DYNC1H1 P4HA2 LIMD1 SYNE1 SKP2 CIT VIRMA SPAG5 CCDC88A C8orf76 MACF1 TNKS | 7.90e-07 | 429 | 259 | 20 | int:DISC1 |
| Interaction | AGO2 interactions | MYH1 MYL4 MARK1 MARK3 ACTN4 HSPA1A HAND2 DNM2 CUL1 VPS37C LIMD1 UBR4 SKP2 VIRMA LIG4 IGBP1 TBK1 ZBTB10 MARK2 C9orf72 RPA1 | 8.84e-07 | 472 | 259 | 21 | int:AGO2 |
| Interaction | DVL2 interactions | MYH7 HIP1 NUP85 MARK1 MARK3 ERC1 ADGRV1 PIK3R4 USP7 PHLPP1 HSPA1A HSPA1B PLS1 HSPD1 CUL1 KRT19 SYNE1 ODF2 RFC2 HMCN1 MACF1 MARK2 RPA1 | 9.54e-07 | 557 | 259 | 23 | int:DVL2 |
| Interaction | TSPAN33 interactions | 1.79e-06 | 65 | 259 | 8 | int:TSPAN33 | |
| Interaction | NHLRC2 interactions | ERC1 APOBR C4A HSPA1A HSPA1B DYNC1H1 LIMD1 RB1 WDR7 KRT86 UBR4 VIRMA VWA5A TBK1 MACF1 CRYBG3 HARS1 RPA1 | 1.89e-06 | 375 | 259 | 18 | int:NHLRC2 |
| Interaction | RSPH6A interactions | 4.23e-06 | 34 | 259 | 6 | int:RSPH6A | |
| Interaction | GAN interactions | SPTAN1 SPTBN5 HSPA1A HSPD1 DNHD1 DNAH10 KRT82 SYNE1 RTTN RNF213 VIRMA CELSR3 CEBPZ RPA1 | 5.40e-06 | 253 | 259 | 14 | int:GAN |
| Interaction | ABTB2 interactions | 6.21e-06 | 101 | 259 | 9 | int:ABTB2 | |
| Interaction | TACSTD2 interactions | NUP85 CYP8B1 SARM1 COG3 AHCTF1 RTTN RNF213 CPD KIAA1586 MTOR | 6.65e-06 | 129 | 259 | 10 | int:TACSTD2 |
| Interaction | SKP2 interactions | KDM5B KIF24 PTGS2 DDX11 CFLAR USP7 PHLPP1 CUL1 ING3 RB1 RFC2 SKP2 CCDC88A MTOR RPA1 | 7.25e-06 | 296 | 259 | 15 | int:SKP2 |
| Interaction | CNTRL interactions | ERC1 HSPA1A HSPA1B DYNC1H1 DNM2 HSPD1 CEP162 CNTRL ARHGEF18 ODF2 VIRMA TBK1 | 7.92e-06 | 193 | 259 | 12 | int:CNTRL |
| Interaction | RAB9A interactions | MARK3 SNAP47 ANKRD27 SNX13 PIK3R4 PIK3C3 VPS13A USP7 MIOS TACC1 TIMM44 HSPA1A ABCC1 WDR7 CNTRL NBEA CPD ECPAS VIRMA CRYBG3 MARK2 C9orf72 | 9.69e-06 | 595 | 259 | 22 | int:RAB9A |
| Interaction | OFD1 interactions | ERC1 USP7 DYNC1H1 DNM2 FAM184A KRT19 KRT81 CEP162 KRT83 KRT86 CNTRL ODF2 SKP2 VIRMA SPAG5 TBK1 | 1.18e-05 | 347 | 259 | 16 | int:OFD1 |
| Interaction | SNAPIN interactions | MYH7 CMYA5 BFSP2 DYNC1H1 DNM2 KRT15 KRT19 HAP1 SPAG5 TRIM69 MACF1 | 1.23e-05 | 169 | 259 | 11 | int:SNAPIN |
| Interaction | NRIP1 interactions | KDM5B ESRRG TRIP12 CCDC85B KPNA3 KPNA4 ODF2 CIT VIRMA MACF1 ERC2 | 1.30e-05 | 170 | 259 | 11 | int:NRIP1 |
| Interaction | GRIN2D interactions | 1.31e-05 | 41 | 259 | 6 | int:GRIN2D | |
| Interaction | ACTN2 interactions | 1.38e-05 | 171 | 259 | 11 | int:ACTN2 | |
| Interaction | YWHAH interactions | KDM5B ABCA2 NET1 MARK1 MARK3 ERC1 SPTAN1 PFDN2 TRIP12 LYST ANKRD27 PIK3R4 AARS2 PIK3C3 HSPA1A UTRN LIMD1 RTCB KRT19 CEP162 CNTRL VIRMA CCDC88A MTOR TBK1 MACF1 CRYBG3 MARK2 C9orf72 RPA1 ALDH7A1 PPP1R12C | 1.42e-05 | 1102 | 259 | 32 | int:YWHAH |
| Interaction | AURKB interactions | ADGRV1 CMYA5 NFKB1 TACC1 DNM1 HSPA1A UTRN DYNC1H1 HSPD1 CUL1 RB1 CNTRL UBR4 RNF213 KIAA1586 NCAPH SKP2 CIT SPAG5 GTF3C1 MACF1 CRYBG3 MARK2 C9orf72 RPA1 | 1.79e-05 | 761 | 259 | 25 | int:AURKB |
| Interaction | AGAP2 interactions | UBE4B SPTAN1 ACTN4 AK5 TLN2 DNM1 DYNC1H1 SYNE1 ARHGEF18 NBEA GRIN2B MACF1 | 1.85e-05 | 210 | 259 | 12 | int:AGAP2 |
| Interaction | DSCR9 interactions | PSMC1 ACTN4 TRIP12 PIK3R4 ATXN10 DYNC1H1 SYNE1 NBEA CELSR3 MACF1 | 2.10e-05 | 147 | 259 | 10 | int:DSCR9 |
| Interaction | STK3 interactions | 2.34e-05 | 181 | 259 | 11 | int:STK3 | |
| Interaction | SBDS interactions | MYH1 MYH2 MYH4 MYH7 MYH8 MYH13 UBE4B SPTBN5 PHKA2 TIMM44 RPA1 | 2.34e-05 | 181 | 259 | 11 | int:SBDS |
| Interaction | VPS33A interactions | ERC1 PSMC1 DDX11 PIK3R4 PHKA1 PIK3C3 DNM2 LIMD1 CNTRL TBK1 TNKS C9orf72 RPA1 | 2.57e-05 | 253 | 259 | 13 | int:VPS33A |
| Interaction | HAUS1 interactions | COG3 BFSP2 HSPA1A VPS37C KRT15 KRT19 CEP162 ODF2 SPAG5 ANKRD13A TRIM69 | 2.60e-05 | 183 | 259 | 11 | int:HAUS1 |
| Interaction | MYH6 interactions | 2.87e-05 | 94 | 259 | 8 | int:MYH6 | |
| Interaction | SCN2B interactions | 3.10e-05 | 95 | 259 | 8 | int:SCN2B | |
| Interaction | H2AC4 interactions | SPTAN1 CHD3 TRIP12 USP7 HSPA1A UNC79 DNM2 CUL1 EP400 DNAH10 RTCB KRT19 RFC2 NCAPH CIT VIRMA GTF3C1 C9orf72 RPA1 | 3.23e-05 | 506 | 259 | 19 | int:H2AC4 |
| Interaction | OCIAD1 interactions | ABCA2 SARM1 COG3 SNAP47 PIK3C3 VPS13A TACC1 ATXN10 TIMM44 HSPA1A CUL1 RNF213 NCAPH RFX2 CRYBG3 C9orf72 RPA1 | 3.24e-05 | 419 | 259 | 17 | int:OCIAD1 |
| Interaction | KRT18 interactions | ERC1 PHLPP1 HSPA1A CCDC85B KRT15 RTCB KRT19 KRT81 CEP162 AHCTF1 RFC2 VIRMA SPAG5 TBK1 CRYBG3 HARS1 RPA1 | 3.24e-05 | 419 | 259 | 17 | int:KRT18 |
| Interaction | KDM1A interactions | KDM5B ERC1 PSMC1 CHD3 USP7 TACC1 HSPA1A HSPA1B UTRN PHLDB3 KRT15 EP400 RB1 KRT19 CEP162 UBR4 ECPAS CIT VIRMA SPAG5 CENPQ CCDC88A GTF3C1 TBK1 ZBTB10 CRYBG3 C9orf72 RPA1 | 3.32e-05 | 941 | 259 | 28 | int:KDM1A |
| Interaction | EZR interactions | MYH13 MARK3 SPTAN1 ACTN4 PTPRC TIMM44 HSPA1A UTRN PLS1 WDR44 CASP10 NBEA CIT VIRMA EFHD1 NEMF MACF1 MARK2 RPA1 ENO2 | 3.40e-05 | 553 | 259 | 20 | int:EZR |
| Interaction | ASAH2 interactions | 4.08e-05 | 6 | 259 | 3 | int:ASAH2 | |
| Interaction | STK4 interactions | 4.12e-05 | 159 | 259 | 10 | int:STK4 | |
| Interaction | FAM107A interactions | 4.22e-05 | 73 | 259 | 7 | int:FAM107A | |
| Interaction | PLEC interactions | HIP1 ATR SPTAN1 STAT6 MCM3AP USP7 PHLPP1 HSPA1A KRT19 AHCTF1 ECT2L NCAPH CIT VIRMA CCDC88A MACF1 RPA1 | 4.48e-05 | 430 | 259 | 17 | int:PLEC |
| Interaction | PCM1 interactions | FILIP1 ERC1 TTC12 PHLPP1 FAM184A KRT15 KRT19 HAP1 KRT81 CEP162 KRT83 KRT86 CNTRL ODF2 ECPAS VIRMA SPAG5 | 5.03e-05 | 434 | 259 | 17 | int:PCM1 |
| Interaction | OSBP interactions | 5.03e-05 | 131 | 259 | 9 | int:OSBP | |
| Interaction | PSMB3 interactions | PSMC1 HSPA1A DYNC1H1 CUL1 ECPAS PAAF1 NCAPH VIRMA KDM2A C9orf72 RPA1 | 5.34e-05 | 198 | 259 | 11 | int:PSMB3 |
| Interaction | PSMD14 interactions | PSMC1 CHD3 CMYA5 HSPA1A HSPA1B HSPD1 DNAH10 RTCB CNTRL UBR4 CASP10 CAMK1 ECPAS PAAF1 VIRMA SPAG5 MTOR C9orf72 RPA1 | 5.58e-05 | 527 | 259 | 19 | int:PSMD14 |
| Interaction | CEP85L interactions | 5.96e-05 | 33 | 259 | 5 | int:CEP85L | |
| Interaction | CALM1 interactions | ANKS6 NET1 ESRRG LYST RYR2 GRAMD1B PHKA1 PHKA2 PIK3C3 MCM3AP VPS13A UTRN CNGA2 DOCK3 CUL1 UBR4 CAMK1 GRIN2B CIT CCDC88A C9orf72 | 6.39e-05 | 626 | 259 | 21 | int:CALM1 |
| Interaction | SWAP70 interactions | 6.48e-05 | 78 | 259 | 7 | int:SWAP70 | |
| Interaction | POLR1G interactions | PFDN2 TRIP12 SPTBN5 NFKB1 USP7 MED21 KPNA3 KPNA4 CUL1 EP400 UBR4 PPIL4 RFC2 CIT GTF3C1 CEBPZ ZBTB10 KDM2A | 6.74e-05 | 489 | 259 | 18 | int:POLR1G |
| Interaction | CENPE interactions | 6.80e-05 | 106 | 259 | 8 | int:CENPE | |
| Interaction | TPX2 interactions | MARK1 MARK3 TRIP12 USP7 PHLPP1 KPNA4 CIT VIRMA TBK1 MARK2 RPA1 | 6.99e-05 | 204 | 259 | 11 | int:TPX2 |
| Interaction | GJA1 interactions | MYH6 MYH7 MARK1 MARK3 SPTAN1 SNAP47 PIK3R4 PIK3C3 VPS13A USP7 TACC1 HSPA1A UTRN ABCC1 NBEA CPD TRIM69 CCDC88A MACF1 MARK2 | 7.06e-05 | 583 | 259 | 20 | int:GJA1 |
| Interaction | POU5F1 interactions | ATR ERC1 ESRRG ETF1 CHD3 USP7 ATXN10 DYNC1H1 KPNA3 HSPD1 EP400 RTCB KRT19 UBR4 ECPAS RFX2 SKP2 CHD5 ZBTB10 RPA1 | 7.23e-05 | 584 | 259 | 20 | int:POU5F1 |
| Interaction | CLASP1 interactions | 7.55e-05 | 138 | 259 | 9 | int:CLASP1 | |
| Interaction | SNRK interactions | 7.99e-05 | 35 | 259 | 5 | int:SNRK | |
| Interaction | TBC1D31 interactions | 8.06e-05 | 56 | 259 | 6 | int:TBC1D31 | |
| Interaction | PIN4 interactions | 8.26e-05 | 81 | 259 | 7 | int:PIN4 | |
| Interaction | HOMER1 interactions | 8.43e-05 | 140 | 259 | 9 | int:HOMER1 | |
| Interaction | ARHGAP30 interactions | 8.87e-05 | 19 | 259 | 4 | int:ARHGAP30 | |
| Interaction | PSMD4 interactions | MYH7 PSMC1 TNFRSF21 PIK3C3 USP7 HSPA1A HSPA1B CUL1 ECPAS PAAF1 VIRMA ANKRD13A NEMF C9orf72 RPA1 | 8.99e-05 | 368 | 259 | 15 | int:PSMD4 |
| Interaction | GNB2 interactions | CYP8B1 ACTN4 PFDN2 CHD3 DDX11 ATXN10 HSPA1A HSPA1B HSPD1 RTCB LAMB2 RNF213 RFC2 ECPAS CCDC88A MTOR TBK1 C9orf72 | 9.39e-05 | 502 | 259 | 18 | int:GNB2 |
| Interaction | HDAC4 interactions | KDM5B MYL4 MARK3 SPTAN1 ETF1 ACTN4 PHKA1 NWD2 TTC7B NFKB1 MIOS TLN2 HSPA1A KPNA3 HSPD1 PITPNM2 HAP1 UBR4 CAMK1 VIRMA NEMF TNKS MARK2 | 9.83e-05 | 744 | 259 | 23 | int:HDAC4 |
| Interaction | HTR6 interactions | 9.83e-05 | 58 | 259 | 6 | int:HTR6 | |
| Interaction | DYRK1A interactions | MYH6 ABCA2 ERC1 SPTAN1 LIN52 TRIP12 KIF24 SLC38A10 OSBPL1A USP7 CCDC15 HSBP1 DNM1 UTRN KPNA4 RB1 CIT VIRMA DNM3 | 1.03e-04 | 552 | 259 | 19 | int:DYRK1A |
| Interaction | LHPP interactions | 1.05e-04 | 37 | 259 | 5 | int:LHPP | |
| Interaction | CASP8 interactions | HIP1 CHD3 CFLAR PIK3C3 USP7 RB1 CASP10 SKP2 ANKRD13A MTOR TLR3 | 1.07e-04 | 214 | 259 | 11 | int:CASP8 |
| Interaction | DDX60L interactions | 1.10e-04 | 20 | 259 | 4 | int:DDX60L | |
| Interaction | KBTBD7 interactions | ERC1 TRIP12 SPTY2D1 WDR44 PHLDB3 HAP1 VIRMA ZNF3 GTF3C1 RPA1 ALDH7A1 | 1.12e-04 | 215 | 259 | 11 | int:KBTBD7 |
| Interaction | TNIK interactions | SPTAN1 TIAM2 DNM1 HSPA1A DYNC1H1 SYNE1 NBEA GRIN2B CIT VIRMA MACF1 ERC2 TNKS HARS1 RPA1 | 1.32e-04 | 381 | 259 | 15 | int:TNIK |
| Interaction | MOB4 interactions | 1.43e-04 | 150 | 259 | 9 | int:MOB4 | |
| Interaction | KDR interactions | 1.43e-04 | 150 | 259 | 9 | int:KDR | |
| Interaction | PSMC6 interactions | PSMC1 HSPA1A CCDC85B UBR4 RFC2 ECPAS PAAF1 NCAPH CIT VIRMA GTF2A1 MTOR C9orf72 RPA1 | 1.47e-04 | 342 | 259 | 14 | int:PSMC6 |
| Interaction | DIRAS3 interactions | HIP1 MARK3 SPTAN1 PSMC1 PIK3C3 ABCC1 NBEA CPD ECPAS CCDC88A MACF1 MARK2 | 1.56e-04 | 262 | 259 | 12 | int:DIRAS3 |
| Interaction | RHOF interactions | HIP1 ATR MARK1 MARK3 SPTAN1 ETF1 ACTN4 EHBP1L1 TTC7B VPS13A ATXN10 HSPA1A UTRN ABCC1 AHCTF1 CPD ECPAS CCDC88A MTOR MACF1 MARK2 | 1.75e-04 | 673 | 259 | 21 | int:RHOF |
| Interaction | PSMC5 interactions | ESRRG PSMC1 PTGS2 BFSP2 HSPA1A DYNC1H1 ABCC1 KRT15 UBR4 ECPAS PAAF1 CIT VIRMA MTOR HARS1 C9orf72 RPA1 | 1.88e-04 | 484 | 259 | 17 | int:PSMC5 |
| Interaction | STAG3 interactions | 1.95e-04 | 23 | 259 | 4 | int:STAG3 | |
| Interaction | CEP192 interactions | 1.97e-04 | 192 | 259 | 10 | int:CEP192 | |
| Interaction | MAPRE3 interactions | FILIP1 MARK3 KIF24 PIK3R4 TACC1 CEP162 SPAG5 CCDC88A ANKRD1 MACF1 MARK2 | 2.02e-04 | 230 | 259 | 11 | int:MAPRE3 |
| Interaction | BSG interactions | ATR ACTN4 COG3 USP7 TACC1 ATXN10 DNM1 HSPA1A DNM2 ABCC1 RNF213 CPD ECPAS VIRMA RNASEL MTOR DNM3 C9orf72 RPA1 ALDH7A1 | 2.03e-04 | 631 | 259 | 20 | int:BSG |
| Interaction | UBASH3A interactions | 2.04e-04 | 124 | 259 | 8 | int:UBASH3A | |
| Interaction | NCBP1 interactions | ERC1 ACTN4 CHD3 NFKB1 HSPA1A DYNC1H1 KPNA3 KPNA4 CUL1 CIT VIRMA MTOR C9orf72 RPA1 | 2.04e-04 | 353 | 259 | 14 | int:NCBP1 |
| Interaction | PPIA interactions | LYST USP7 TLN2 TACC1 HSPA1A CUL1 EP400 LIMD1 RB1 KRT83 ECPAS CIT VIRMA SPAG5 SMTN REXO2 GTF2A1 LIG4 IGBP1 MACF1 KDM2A CRYBG3 C9orf72 RPA1 ALDH7A1 | 2.10e-04 | 888 | 259 | 25 | int:PPIA |
| Interaction | KIAA1671 interactions | 2.15e-04 | 194 | 259 | 10 | int:KIAA1671 | |
| Interaction | LUZP1 interactions | PHLPP1 HSPA1A KRT19 CEP162 CNTRL ODF2 CIT VIRMA CCDC88A RPA1 | 2.15e-04 | 194 | 259 | 10 | int:LUZP1 |
| Interaction | AURKC interactions | 2.18e-04 | 43 | 259 | 5 | int:AURKC | |
| Interaction | ST13 interactions | 2.24e-04 | 195 | 259 | 10 | int:ST13 | |
| Interaction | RYR3 interactions | 2.31e-04 | 24 | 259 | 4 | int:RYR3 | |
| Interaction | DEPP1 interactions | 2.36e-04 | 10 | 259 | 3 | int:DEPP1 | |
| Interaction | MECOM interactions | MYH1 MYH2 MYH4 MYH7 MYH8 PSMC1 CHD3 USP7 TIMM44 DYNC1H1 PLXNB1 AHCTF1 NCAPH VIRMA | 2.36e-04 | 358 | 259 | 14 | int:MECOM |
| Interaction | ACTR1A interactions | PFDN2 COG3 HSPA1A DYNC1H1 KPNA3 KPNA4 CUL1 DNAH10 NCAPH VIRMA C9orf72 RPA1 | 2.36e-04 | 274 | 259 | 12 | int:ACTR1A |
| Interaction | HNRNPCL2 interactions | TRIT1 NET1 MARK3 CHD3 TRIP12 ECT2L RFC2 SKP2 CIT VIRMA RNASEL RTCA | 2.36e-04 | 274 | 259 | 12 | int:HNRNPCL2 |
| Interaction | PRKAG2 interactions | 2.39e-04 | 68 | 259 | 6 | int:PRKAG2 | |
| Interaction | HTT interactions | ATP5F1D KDM5B MYH6 HIP1 ERC1 SPTAN1 CHD3 STX1B AK5 MED21 TACC1 ATXN10 DNM1 HSPA1A DYNC1H1 DNM2 HSPD1 HAP1 PPIL4 GRIN2B VIRMA MTOR EFHD1 ERC2 MARK2 RPA1 | 2.39e-04 | 949 | 259 | 26 | int:HTT |
| Interaction | NIN interactions | MYH13 ERC1 TIMM44 DYNC1H1 FAM184A LIMD1 KRT19 CEP162 CNTRL ODF2 CIT VIRMA SPAG5 TBK1 | 2.43e-04 | 359 | 259 | 14 | int:NIN |
| Interaction | EPHA1 interactions | MARK3 AARS2 ATXN10 HSPA1B DYNC1H1 EP400 DNAH10 SYNE1 CASP10 CAMK1 CCDC88A | 2.43e-04 | 235 | 259 | 11 | int:EPHA1 |
| Interaction | STYK1 interactions | 2.43e-04 | 161 | 259 | 9 | int:STYK1 | |
| Interaction | HAUS6 interactions | 2.43e-04 | 161 | 259 | 9 | int:HAUS6 | |
| Interaction | IGBP1 interactions | 2.55e-04 | 162 | 259 | 9 | int:IGBP1 | |
| Interaction | SEM1 interactions | 2.55e-04 | 162 | 259 | 9 | int:SEM1 | |
| Interaction | YWHAQ interactions | MYH2 KDM5B MYH7 MYH13 MARK1 MARK3 ERC1 PFDN2 TRIP12 LYST AARS2 PIK3C3 NFKB1 HSPA1A UNC79 DYNC1H1 RTCB KRT19 CEP162 VIRMA P3H4 CCDC88A MTOR MACF1 MARK2 C9orf72 RPA1 ALDH7A1 PPP1R12C | 2.61e-04 | 1118 | 259 | 29 | int:YWHAQ |
| Cytoband | 12q13 | 5.68e-05 | 71 | 263 | 5 | 12q13 | |
| GeneFamily | Myosin heavy chains | 2.73e-13 | 15 | 167 | 8 | 1098 | |
| GeneFamily | EF-hand domain containing | 3.74e-05 | 219 | 167 | 10 | 863 | |
| GeneFamily | Keratins, type II | 1.04e-04 | 27 | 167 | 4 | 609 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.53e-04 | 3 | 167 | 2 | 287 | |
| GeneFamily | Ankyrin repeat domain containing | ANKS6 ANKRD27 NFKB1 OSBPL1A ANKRD13A RNASEL ANKRD1 TNKS PPP1R12C | 4.25e-04 | 242 | 167 | 9 | 403 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.69e-04 | 206 | 167 | 8 | 682 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 1.24e-03 | 6 | 167 | 2 | 1342 | |
| GeneFamily | Sterile alpha motif domain containing | 1.34e-03 | 88 | 167 | 5 | 760 | |
| GeneFamily | PHD finger proteins | 1.48e-03 | 90 | 167 | 5 | 88 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.73e-03 | 7 | 167 | 2 | 1113 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 1.73e-03 | 7 | 167 | 2 | 1201 | |
| GeneFamily | Caspases|Death effector domain containing|Ripoptosome|Death inducing signaling complex | 1.73e-03 | 7 | 167 | 2 | 1019 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.93e-03 | 9 | 167 | 2 | 1234 | |
| GeneFamily | Adenylate kinases | 2.93e-03 | 9 | 167 | 2 | 356 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.93e-03 | 9 | 167 | 2 | 1230 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.24e-03 | 66 | 167 | 4 | 722 | |
| GeneFamily | Cyclic nucleotide gated channels | 3.64e-03 | 10 | 167 | 2 | 250 | |
| GeneFamily | PHD finger proteins|NuRD complex | 5.27e-03 | 12 | 167 | 2 | 1305 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | ATP8B4 KIF24 SLC38A10 OSBPL1A ABCC1 CNTRL AOAH CENPQ SLC16A6 CRYBG3 CDC6 | 5.93e-06 | 200 | 262 | 11 | M6661 |
| Coexpression | ZHU_CMV_ALL_UP | 1.24e-05 | 107 | 262 | 8 | M19630 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 1.33e-05 | 108 | 262 | 8 | MM1334 | |
| Coexpression | ZHU_CMV_24_HR_UP | 1.85e-05 | 82 | 262 | 7 | M15565 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | NUP85 ATR ADGRV1 NFKB1 TACC1 TIMM44 CNTRL RFC2 NCAPH CIT SPAG5 CENPQ C8orf76 CDC6 RPA1 | 3.34e-05 | 432 | 262 | 15 | MM419 |
| Coexpression | GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN | 3.42e-05 | 199 | 262 | 10 | M9846 | |
| Coexpression | GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN | KDM5B ABCA2 TTC12 OSBPL1A ABCC1 SYNE1 RNF213 IGBP1 IFTAP ENO2 | 3.42e-05 | 199 | 262 | 10 | M7485 |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | TRIP12 PTPRC MCM3AP VPS13A WDR44 UBR4 GOLGA8B MACF1 GOLGA8A ENO2 | 3.57e-05 | 200 | 262 | 10 | M9889 |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 4.17e-05 | 20 | 262 | 4 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 5.11e-05 | 21 | 262 | 4 | MM1102 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_UP | 5.36e-05 | 41 | 262 | 5 | M1415 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_UP | 6.78e-05 | 43 | 262 | 5 | MM619 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | KDM5B MYL4 NET1 UBE4B MARK3 ETF1 PSMC1 NDUFAB1 TRIP12 DDX11 CFLAR PTPRC PIK3C3 NFKB1 MED21 C4A ATXN10 WDR44 DNM2 KPNA3 KPNA4 ABCC1 RTCB CASP10 CPD TBK1 RTCA NEMF NPRL3 RPA1 | 7.21e-05 | 1399 | 262 | 30 | M535 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | HIP1 UBE4B ADGRV1 LIN52 GRAMD1B OSBPL1A TLN2 DNM1 DHTKD1 DNM2 GRIN2B WDR19 KDM2A MARK2 | 8.74e-05 | 417 | 262 | 14 | M39224 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 8.78e-05 | 180 | 262 | 9 | M8239 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_ILCP_CELL | 9.55e-05 | 182 | 262 | 9 | M45771 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | TRIT1 HIP1 ATR UBE4B LYST PTGS2 HSPA1A HSPA1B DEXI RTCB WDR7 UBR4 CPD ZBTB10 KDM2A | 1.02e-04 | 477 | 262 | 15 | M40930 |
| Coexpression | BENPORATH_CYCLING_GENES | KDM5B DDX11 CFLAR C4B VPS37C DEXI KIAA1586 ODF2 RFC2 NCAPH CIT SPAG5 SMTN CENPQ FLAD1 CDC6 GOLGA8A STAG3 | 1.02e-04 | 648 | 262 | 18 | M8156 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | ETF1 TNFRSF21 PGGT1B PTGS2 SNX13 MED21 UTRN SPTY2D1 SLC16A6 ZBTB10 C9orf72 | 1.14e-04 | 276 | 262 | 11 | M41128 |
| Coexpression | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION | 1.16e-04 | 48 | 262 | 5 | M16123 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | NEK6 DDX11 NWD2 C4A C4B DHTKD1 DDX11L8 CCDC85B PITPNM2 ABCC1 DDX12P PPIL4 ECPAS WDR19 CEBPZ MTOR ZBTB10 | 1.26e-04 | 600 | 262 | 17 | MM1025 |
| Coexpression | WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53 | 1.54e-04 | 11 | 262 | 3 | M6312 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | KDM5B ATR MARK3 ERC1 TRIP12 SNX13 PIK3R4 PIK3C3 NFKB1 VPS13A USP7 PHLPP1 KPNA3 CUL1 ABCC1 RB1 WDR7 AHCTF1 MACF1 TNKS CRYBG3 | 1.55e-04 | 856 | 262 | 21 | M4500 |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_DN | 1.81e-04 | 198 | 262 | 9 | M9747 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | 1.81e-04 | 198 | 262 | 9 | M4415 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN | 1.95e-04 | 200 | 262 | 9 | M3237 | |
| Coexpression | GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP | 1.95e-04 | 200 | 262 | 9 | M9689 | |
| Coexpression | GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN | 1.95e-04 | 200 | 262 | 9 | M9761 | |
| Coexpression | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 1.95e-04 | 200 | 262 | 9 | M78 | |
| Coexpression | GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP | 1.95e-04 | 200 | 262 | 9 | M5102 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP | SPTAN1 STAT6 SLC38A10 MCM3AP DOCK3 WDR7 LAMB2 ARHGEF18 CAMK1 | 1.95e-04 | 200 | 262 | 9 | M5154 |
| Coexpression | HALLMARK_MYOGENESIS | 1.95e-04 | 200 | 262 | 9 | M5909 | |
| Coexpression | GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN | 1.95e-04 | 200 | 262 | 9 | M3199 | |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | MYL4 NUP85 PSMC1 NDUFAB1 AK7 DDX11 CCDC15 TLN2 TIMM44 PLS1 KPNA3 HSPD1 DEXI RTCB KIAA1586 RFC2 NFS1 NCAPH CIT SPAG5 REXO2 IFTAP NPRL3 HARS1 CDC6 RPA1 CPSF3 | 1.96e-04 | 1271 | 262 | 27 | M39197 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | SPTLC3 FILIP1 MYH1 MYH2 MYH7 MYH8 MYL4 PTGS2 RYR2 RYR3 EHBP1L1 CLCA1 TACC1 HSPA1A HSPA1B SPTY2D1 HAND2 WDR44 DNM2 KRT15 KRT19 CPD SMTN ANKRD1 TLR3 | 7.78e-06 | 772 | 256 | 25 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_100 | 9.43e-06 | 86 | 256 | 8 | gudmap_developingLowerUrinaryTract_P1_bladder_100_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | SPTLC3 FILIP1 MYH2 MYH7 MYH8 MYL4 PTGS2 RYR3 CLCA1 HSPA1A HSPA1B HAND2 KRT15 KRT19 SMTN ANKRD1 | 2.13e-05 | 388 | 256 | 16 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.68e-05 | 161 | 256 | 10 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#3_top-relative-expression-ranked_200 | 7.79e-05 | 37 | 256 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_200_k3 | |
| CoexpressionAtlas | kidney single cell_adult_RenalCortexMixed_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_200 | 1.45e-04 | 2 | 256 | 2 | gudmap_kidney single cell_adult_RenalCortexMixed_Scamp_k1_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000 | FILIP1 MYH1 MYH2 BNC2 MYH6 MYH7 MYH8 MYL4 RYR2 RYR3 EHBP1L1 CLCA1 HPGD SPON2 HSPA1A HSPA1B HAND2 CCDC85B SMTN REXO2 IFTAP PPP1R12C | 1.47e-04 | 761 | 256 | 22 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_200 | 1.52e-04 | 161 | 256 | 9 | gudmap_developingLowerUrinaryTract_P1_bladder_200_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#3_top-relative-expression-ranked_100 | 1.53e-04 | 23 | 256 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 1.74e-04 | 129 | 256 | 8 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_200 | 1.75e-04 | 164 | 256 | 9 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_200 | 1.81e-04 | 24 | 256 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k4 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.SLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-2 | NEK6 NET1 LYST PTGS2 CFLAR PHLPP1 HSPA1A HSPA1B GTF2A1 CCDC88A VWA5A ZBTB10 LTC4S C9orf72 ENO2 | 1.86e-04 | 419 | 256 | 15 | GSM854285_500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH1 ADGRV1 PKD1L2 RYR2 RYR3 CAPN8 TLN2 UNC79 DNAH10 GRIN2B HMCN1 MYH15 SPAG17 | 8.21e-11 | 184 | 263 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH1 ADGRV1 PKD1L2 RYR2 RYR3 CAPN8 TLN2 UNC79 DNAH10 GRIN2B HMCN1 MYH15 SPAG17 | 8.21e-11 | 184 | 263 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH1 ADGRV1 PKD1L2 RYR2 RYR3 CAPN8 TLN2 UNC79 DNAH10 GRIN2B HMCN1 MYH15 SPAG17 | 8.21e-11 | 184 | 263 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH8 MYL4 ESRRG ADGRV1 RYR2 RYR3 CAPN8 DNAH10 GRIN2B HMCN1 MYH15 | 3.18e-09 | 160 | 263 | 11 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH8 MYL4 ESRRG ADGRV1 RYR2 RYR3 CAPN8 DNAH10 GRIN2B HMCN1 MYH15 | 3.18e-09 | 160 | 263 | 11 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-07 | 184 | 263 | 10 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | MYH13 ADGRV1 APOBR KIF24 PTGS2 RYR2 GRIN2B CCDC88A MYH15 SPAG17 | 1.70e-07 | 186 | 263 | 10 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-07 | 187 | 263 | 10 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-07 | 187 | 263 | 10 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-07 | 187 | 263 | 10 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | NET1 CMYA5 TNFRSF21 CAPN8 HPGD PHLPP1 KRT15 KRT19 KRT86 ELF3 | 2.40e-07 | 193 | 263 | 10 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.64e-07 | 195 | 263 | 10 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.64e-07 | 195 | 263 | 10 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-07 | 198 | 263 | 10 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-07 | 169 | 263 | 9 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 178 | 263 | 9 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.30e-06 | 180 | 263 | 9 | 1bc01bb76d0d3f8db74f9244436d3e6d6015ed5d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.30e-06 | 180 | 263 | 9 | 2a28fbfe10a340c8662c2c8be33792f41fc09088 | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 1.30e-06 | 180 | 263 | 9 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.30e-06 | 180 | 263 | 9 | 12f3c4c4aa7fe03c0ef847bd4d4942c808015f5f | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 1.30e-06 | 180 | 263 | 9 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | IPF-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 1.49e-06 | 183 | 263 | 9 | 9b507547e6adf78e46e7f542cd9958224ec5826a | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.86e-06 | 188 | 263 | 9 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-06 | 188 | 263 | 9 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.12e-06 | 191 | 263 | 9 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.31e-06 | 193 | 263 | 9 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.41e-06 | 194 | 263 | 9 | 5da8873cddff582e5693b32fd3aaebc102f65fc0 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.41e-06 | 194 | 263 | 9 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | NEK6 TNFRSF21 GRAMD1B OSBPL1A TFEC CCDC88A SLC16A6 VWA5A C9orf72 | 2.52e-06 | 195 | 263 | 9 | 9d649ac7d2af313481069c95349efc0c68449e2b |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.52e-06 | 195 | 263 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.52e-06 | 195 | 263 | 9 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.52e-06 | 195 | 263 | 9 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | (0)_NK/T_cells-(0)_NK_T_CD8_Cytotoxic|(0)_NK/T_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.52e-06 | 195 | 263 | 9 | 13717c6e42882162445bc1b1445d66efcb68e19d | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 2.62e-06 | 196 | 263 | 9 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-06 | 196 | 263 | 9 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.62e-06 | 196 | 263 | 9 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | lymphoid-NK_cell-NK_cell|lymphoid / Lineage, cell class and subclass | 2.62e-06 | 196 | 263 | 9 | 5e6238fe131e349013c60a73c99f84a6be7955ef | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.62e-06 | 196 | 263 | 9 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | lymphoid-NK_cell|lymphoid / Lineage, cell class and subclass | 2.62e-06 | 196 | 263 | 9 | 0c7fb03ef782256f61624afc5c1bfaed9f1005fb | |
| ToppCell | COVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class | 2.71e-06 | 147 | 263 | 8 | baf15c773d7751bc6f64d4974a22738626f2b3ff | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.74e-06 | 197 | 263 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.74e-06 | 197 | 263 | 9 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.85e-06 | 198 | 263 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.85e-06 | 198 | 263 | 9 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.85e-06 | 198 | 263 | 9 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.85e-06 | 198 | 263 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.85e-06 | 198 | 263 | 9 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Control-NK|Control / Disease condition and Cell class | 2.97e-06 | 199 | 263 | 9 | f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.97e-06 | 199 | 263 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.97e-06 | 199 | 263 | 9 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class | 3.10e-06 | 200 | 263 | 9 | 6560753d3df2f87860b52052d4881aa45410f666 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | SPTAN1 SAMD9L HPGD DYNC1H1 CCDC85B PITPNM2 RNF213 CASP10 PLA2G4C | 3.10e-06 | 200 | 263 | 9 | 89821a264e872ed53e08e9d3609d5cc5c314503e |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SPTAN1 SAMD9L HPGD OSBPL1A DYNC1H1 PITPNM2 RNF213 PLA2G4C MACF1 | 3.10e-06 | 200 | 263 | 9 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.10e-06 | 200 | 263 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | RA-05._Cytoplasmic_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.10e-06 | 200 | 263 | 9 | 0c249391b27619b62608f164abc0b72b55116cb0 | |
| ToppCell | RA-05._Cytoplasmic_Cardiomyocyte_I|RA / Chamber and Cluster_Paper | 3.10e-06 | 200 | 263 | 9 | e75d0e13a8f519a779d88e631bc92ff1819033f5 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.10e-06 | 200 | 263 | 9 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 4.22e-06 | 156 | 263 | 8 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-06 | 113 | 263 | 7 | 357bc20edc5bc14eab8262d52260ed1686e9dc54 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-06 | 113 | 263 | 7 | 91e73e3b93be242fef0f14eddd8085a1f1c730ef | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-06 | 160 | 263 | 8 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.84e-06 | 116 | 263 | 7 | f2bf9599040f43b5ea8724841d7b71c0a859c016 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 167 | 263 | 8 | 528493896aebe7d03d4b6ad2341b12927859e2e4 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 167 | 263 | 8 | a82e85caf79395baa48380786d9df32a86dfd1ce | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.60e-06 | 169 | 263 | 8 | d4a0bd792bddfa34332d7dc432ce253f50d98c6f | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.94e-06 | 170 | 263 | 8 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.28e-06 | 171 | 263 | 8 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | COPD-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 9.02e-06 | 173 | 263 | 8 | 4a0043b29f8ede5a74bdb38cbf2c70e12b25e130 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.81e-06 | 175 | 263 | 8 | 8fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 176 | 263 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 180 | 263 | 8 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.23e-05 | 130 | 263 | 7 | a3e12984fb61311e49cc76c59f74f4dffc48faa1 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.25e-05 | 181 | 263 | 8 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 182 | 263 | 8 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-05 | 182 | 263 | 8 | 818b5155ec81f0059048d6070a108116ecd72e3c | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-05 | 183 | 263 | 8 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 184 | 263 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.41e-05 | 184 | 263 | 8 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.47e-05 | 185 | 263 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Monocytes-IL1B+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.47e-05 | 185 | 263 | 8 | cbe54b605f417a01b3b5d2ec75565ee3b5a9ba06 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.53e-05 | 186 | 263 | 8 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.58e-05 | 135 | 263 | 7 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-05 | 187 | 263 | 8 | c667fae6440dc98072b584f203d00f0fb1cb2f21 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.59e-05 | 187 | 263 | 8 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.65e-05 | 188 | 263 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 1.65e-05 | 188 | 263 | 8 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.71e-05 | 189 | 263 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-05 | 189 | 263 | 8 | 5c85656f555d91ecc9540faa67717694a4aef92f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.78e-05 | 190 | 263 | 8 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.78e-05 | 190 | 263 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.78e-05 | 190 | 263 | 8 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.85e-05 | 191 | 263 | 8 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.85e-05 | 191 | 263 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-05 | 192 | 263 | 8 | 690cf19e9b0b2ada80097c63eae827529aa5b6f3 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.92e-05 | 192 | 263 | 8 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-05 | 192 | 263 | 8 | 3d6c4c5847ca1e44fa380403d25af45d5b51ee9b | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-05 | 192 | 263 | 8 | e0412964a3ee1bf3c0ef64f9a6f20f7e7835701e | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.92e-05 | 192 | 263 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-05 | 192 | 263 | 8 | b5871247a5f3e970fa05b33fff21bef9d2ab5741 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 193 | 263 | 8 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| Drug | trifluoperazine | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYH13 SPTAN1 PTGS2 AK7 SPTBN5 PHKA1 PHKA2 C4A ALOX15 CHRNA6 ALDH7A1 PPP1R12C | 3.58e-08 | 324 | 258 | 18 | CID000005566 |
| Drug | AC1L1IZ2 | ATP5F1D MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYH13 AK7 RYR2 RYR3 PHKA2 AK5 DYNC1H1 HSPD1 RFC2 GTF3C1 | 7.89e-08 | 304 | 258 | 17 | CID000004795 |
| Drug | formycin triphosphate | 1.02e-07 | 51 | 258 | 8 | CID000122274 | |
| Drug | LY294002 | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYH13 ESRRG PTGS2 STAT6 PIK3R4 CFLAR PTPRC PIK3C3 NFKB1 RB1 CEP162 ARHGEF18 CASP10 SKP2 THPO NOX1 MTOR TLR3 TNKS MARK2 ALDH7A1 | 1.26e-07 | 748 | 258 | 27 | CID000003973 |
| Drug | purealin | 2.87e-07 | 58 | 258 | 8 | CID006419303 | |
| Drug | fast white | 4.25e-07 | 42 | 258 | 7 | CID000024008 | |
| Drug | SM-2 | 6.36e-07 | 87 | 258 | 9 | CID000486033 | |
| Drug | creatine | 2.23e-06 | 193 | 258 | 12 | CID000000586 | |
| Drug | Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | MYH4 ABCA2 SPTBN5 CFLAR AOAH ECPAS GTF2A1 RNASEL CELSR3 VWA5A DNM3 STAG3 | 2.35e-06 | 194 | 258 | 12 | 6308_UP |
| Drug | AC1LADJ6 | 2.37e-06 | 130 | 258 | 10 | CID000486032 | |
| Drug | pyriproxyfen | 5.12e-06 | 23 | 258 | 5 | CID000091753 | |
| Drug | flavone | 9.83e-06 | 44 | 258 | 6 | ctd:C043562 | |
| Drug | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | MYH4 CYP19A1 ESRRG PTGS2 CFLAR PIK3C3 NFKB1 HSPA1B DYNC1H1 ABCC1 RB1 CASP10 THPO NOX1 MTOR TLR3 | 1.47e-05 | 400 | 258 | 16 | ctd:C085911 |
| Drug | AC1NRAG8 | 1.47e-05 | 14 | 258 | 4 | CID005287861 | |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | HIP1 SPTAN1 SNX13 CFLAR HPGD TLN2 LIMD1 ECPAS SKP2 NOX1 DNM3 | 1.49e-05 | 195 | 258 | 11 | 4737_DN |
| Drug | Cocaine | MYH6 MYH7 MARK1 SPTAN1 ETF1 SLC12A8 STX1B RYR2 TIAM2 RYR3 CFLAR GDAP1L1 TTC7B NFKB1 OSBPL1A USP7 TACC1 DNM1 HSPA1A HSPA1B DNM2 HSPD1 KRT15 SYNE1 UBR4 GRIN2B GRIN2D SMTN CCDC88A SLC16A6 NPRL3 DNM3 ENO2 | 1.55e-05 | 1314 | 258 | 33 | ctd:D003042 |
| Drug | Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A | ABCA2 MYL4 RYR2 DNAJC28 VPS13A CEP162 CNTRL CAMK1 ECPAS PLA2G4C KDM2A | 1.56e-05 | 196 | 258 | 11 | 4403_DN |
| Drug | Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; MCF7; HT_HG-U133A | UBE4B LYST RYR2 CFLAR DNM2 ABCC1 FAM184A CEP162 CAMK1 ECPAS GTF2A1 | 1.64e-05 | 197 | 258 | 11 | 4717_DN |
| Drug | Dubinidine [22964-77-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A | MYL4 SPTAN1 LYST HPGD VPS13A MIOS KRT83 CASP10 ZNF3 CHD5 ALDH7A1 | 1.64e-05 | 197 | 258 | 11 | 3554_UP |
| Drug | Aminocaproic acid [60-32-2]; Down 200; 30.4uM; HL60; HT_HG-U133A | ATP5F1D SPTLC3 HIP1 SPTAN1 SLC12A8 PGGT1B DNM2 UBR4 CASP10 NPRL3 MYH15 | 1.64e-05 | 197 | 258 | 11 | 3122_DN |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | ATR UBE4B SARM1 PGGT1B CFLAR HPGD UTRN CAMK1 ODF2 SKP2 NPRL3 | 1.72e-05 | 198 | 258 | 11 | 2062_DN |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | ABCA2 MYL4 UBE4B PGGT1B CFLAR VPS13A TACC1 SMTN LIG4 RNASEL MACF1 | 1.80e-05 | 199 | 258 | 11 | 2654_DN |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; MCF7; HT_HG-U133A | KDM5B MYL4 RYR2 MIOS UTRN HAP1 SYNE1 GRIN2B GTF2A1 VWA5A MARK2 | 1.80e-05 | 199 | 258 | 11 | 3265_UP |
| Drug | Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; MCF7; HT_HG-U133A | ERC1 CHD3 STAT6 CFLAR EHBP1L1 TACC1 DNM2 CAMK1 SKP2 LIG4 ENO2 | 1.80e-05 | 199 | 258 | 11 | 1703_DN |
| Drug | S-(-)-Etomoxir | 1.85e-05 | 100 | 258 | 8 | CID000060765 | |
| Drug | AC1L1C1F | 1.86e-05 | 49 | 258 | 6 | CID000001699 | |
| Drug | al-Badry | 1.97e-05 | 165 | 258 | 10 | CID000004545 | |
| Drug | AC1O3MDH | 2.14e-05 | 102 | 258 | 8 | CID006332158 | |
| Drug | Botulinum Toxins, Type A | 2.63e-05 | 16 | 258 | 4 | ctd:D019274 | |
| Drug | Velcade (bortezomib | PSMC1 LYST PGGT1B CFLAR NFKB1 KRT15 KRT19 KRT81 KRT82 KRT83 KRT86 CASP10 SKP2 MTOR TNKS | 2.64e-05 | 374 | 258 | 15 | CID000093860 |
| Drug | AC1NRBPQ | 2.72e-05 | 137 | 258 | 9 | CID005288569 | |
| Drug | ATBI | 4.35e-05 | 18 | 258 | 4 | CID000505862 | |
| Drug | 2-Cl | 4.42e-05 | 35 | 258 | 5 | CID000081058 | |
| Drug | ostreasterol | 4.87e-05 | 7 | 258 | 3 | CID000092113 | |
| Drug | AC1N9ZZC | 5.26e-05 | 149 | 258 | 9 | CID004369374 | |
| Drug | blebbistatin | 5.40e-05 | 116 | 258 | 8 | CID003476986 | |
| Drug | baicalein | 5.97e-05 | 87 | 258 | 7 | ctd:C006680 | |
| Drug | CHEMBL154623 | 6.65e-05 | 38 | 258 | 5 | CID010457096 | |
| Drug | R4--a | 6.77e-05 | 20 | 258 | 4 | CID005289251 | |
| Drug | Terfenadine [50679-08-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 6.83e-05 | 191 | 258 | 10 | 2227_DN | |
| Drug | oxovanadium | 6.87e-05 | 120 | 258 | 8 | CID000024411 | |
| Drug | AC1L9MJT | 7.14e-05 | 192 | 258 | 10 | CID000448959 | |
| Drug | Fillalbin [4540-25-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 7.14e-05 | 192 | 258 | 10 | 2813_UP | |
| Drug | 2-nitroisocitrate | 7.22e-05 | 62 | 258 | 6 | CID000166578 | |
| Drug | Polyethyleneimine | 7.42e-05 | 90 | 258 | 7 | ctd:D011094 | |
| Drug | beta-Naphthoflavone | CYP19A1 GDF6 PSMC1 PTGS2 NECAB1 HPGD MCM3AP MIOS ATXN10 DNM1 HSPA1A HSPA1B UTRN DYNC1H1 CCDC85B ABCC1 RB1 KRT19 NFS1 SPAG5 SLC16A6 ANKRD1 LTC4S | 7.52e-05 | 828 | 258 | 23 | ctd:D019324 |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 7.78e-05 | 194 | 258 | 10 | 5880_UP | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | MYL4 LYST TNFRSF21 CFLAR EHBP1L1 MCM3AP TACC1 KRT83 NOX1 MARK2 | 7.78e-05 | 194 | 258 | 10 | 3169_DN |
| Drug | F0447-0125; Up 200; 10uM; MCF7; HT_HG-U133A | 7.78e-05 | 194 | 258 | 10 | 6424_UP | |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | ABCA2 SLC12A8 RYR2 CFLAR PHKA2 DNAJC28 CEP162 CPD GTF2A1 LIG4 | 8.12e-05 | 195 | 258 | 10 | 2241_DN |
| Drug | 2bq7 | 8.18e-05 | 123 | 258 | 8 | CID006540267 | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | HIP1 ABCA2 MYL4 PHKA2 EHBP1L1 OSBPL1A DNM1 PLXNB1 ALOX15 CEP162 | 8.48e-05 | 196 | 258 | 10 | 3217_DN |
| Drug | nifedipine | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYH13 CYP8B1 CYP19A1 PTGS2 RYR2 RYR3 GRIN2B GRIN2D ALDH7A1 | 8.58e-05 | 415 | 258 | 15 | CID000004485 |
| Drug | Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 8.84e-05 | 197 | 258 | 10 | 6095_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 8.84e-05 | 197 | 258 | 10 | 7011_DN | |
| Drug | Colistin sulfate [1264-72-8]; Down 200; 3uM; MCF7; HT_HG-U133A | SPTLC3 SPTAN1 EHBP1L1 VPS13A TLN2 DNM2 EP400 LAMB2 ODF2 NOX1 | 8.84e-05 | 197 | 258 | 10 | 4796_DN |
| Drug | NSC226080 | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYH13 ACTN4 RYR2 RYR3 CFLAR PIK3C3 NFKB1 USP7 RB1 PPIL4 SKP2 IGBP1 MTOR NPRL3 HARS1 RPA1 | 9.01e-05 | 782 | 258 | 22 | CID000005040 |
| Drug | berberine | UBE4B PTGS2 PTPRC DNM1 KRT15 KRT19 HAP1 LIG4 CCDC88A NPRL3 TNKS ENO2 | 9.10e-05 | 280 | 258 | 12 | CID000002353 |
| Drug | 13,14-dihydro-15-ketoprostaglandin E2 | 9.16e-05 | 125 | 258 | 8 | CID004307039 | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 9.22e-05 | 198 | 258 | 10 | 5476_DN | |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; HL60; HG-U133A | 9.22e-05 | 198 | 258 | 10 | 2010_DN | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A | HIP1 ABCA2 SPTAN1 CFLAR PHKA2 OSBPL1A TLN2 PLXNB1 NOX1 MARK2 | 9.61e-05 | 199 | 258 | 10 | 1500_DN |
| Drug | Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; PC3; HT_HG-U133A | 9.61e-05 | 199 | 258 | 10 | 7281_UP | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; HL60; HG-U133A | ATP5F1D HIP1 MYL4 ATR APOBR MCM3AP PHLPP1 TIMM44 ABCC1 WDR19 | 9.61e-05 | 199 | 258 | 10 | 1568_DN |
| Drug | valdecoxib; Up 200; 10uM; PC3; HT_HG-U133A | SPTLC3 CHD3 SNX13 SPTBN5 TTC12 VPS13A UTRN CEP162 MTOR STAG3 | 1.00e-04 | 200 | 258 | 10 | 6408_UP |
| Drug | 4-epidoxorubicin | MYH1 MYH2 MYH4 MYH6 MYH7 MYH8 MYH13 ESRRG ACTN4 PTGS2 CFLAR PIK3C3 NFKB1 USP7 HSPD1 ABCC1 RB1 CASP10 SKP2 MTOR LTC4S MARK2 | 1.01e-04 | 788 | 258 | 22 | CID000001690 |
| Drug | 4-chloroaniline | 1.09e-04 | 202 | 258 | 10 | CID000007812 | |
| Drug | phorbol acetate myristate | MYH6 ESRRG PTGS2 STX1B RYR2 RYR3 DDX11 PIK3R4 CFLAR EHBP1L1 SAMD9L PTPRC PIK3C3 HPGD NFKB1 MED21 PHLPP1 ALOX15 ABCC1 KRT15 RB1 KRT19 KRT81 KRT82 KRT83 KRT86 CAMK1 WDR19 THPO MTOR TBK1 MARK2 | 1.24e-04 | 1399 | 258 | 32 | CID000004792 |
| Drug | 11-hydroxy-5,8,12,14-eicosatetraenoic acid | 1.28e-04 | 2 | 258 | 2 | ctd:C027356 | |
| Drug | melicopicine | 1.28e-04 | 2 | 258 | 2 | CID000101253 | |
| Drug | Dametralast | 1.28e-04 | 2 | 258 | 2 | CID000068910 | |
| Drug | acephylline | 1.28e-04 | 2 | 258 | 2 | CID000069550 | |
| Drug | tebuquine | 1.28e-04 | 2 | 258 | 2 | CID000071991 | |
| Drug | diethyl acetylenedicarboxylate | 1.28e-04 | 2 | 258 | 2 | CID000069803 | |
| Drug | 3,5-di-O-galloylquinic acid | 1.28e-04 | 2 | 258 | 2 | CID000460896 | |
| Drug | NSC641520 | 1.32e-04 | 69 | 258 | 6 | CID000003593 | |
| Drug | AC1L2Y08 | HIP1 PSMC1 PGGT1B PTGS2 CFLAR AK5 NFKB1 DNM1 HSPD1 CUL1 RB1 CASP10 SKP2 MTOR NPRL3 | 1.33e-04 | 432 | 258 | 15 | CID000105082 |
| Drug | NSC339663 | 1.41e-04 | 250 | 258 | 11 | CID000003892 | |
| Drug | Bactocill | 1.57e-04 | 135 | 258 | 8 | CID000004607 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.24e-15 | 10 | 255 | 8 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.24e-15 | 10 | 255 | 8 | DOID:0111596 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.24e-15 | 10 | 255 | 8 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.24e-15 | 10 | 255 | 8 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.24e-15 | 10 | 255 | 8 | DOID:0111605 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.24e-15 | 10 | 255 | 8 | DOID:0111269 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.24e-15 | 10 | 255 | 8 | DOID:0110454 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.24e-15 | 10 | 255 | 8 | DOID:0080326 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.34e-14 | 12 | 255 | 8 | DOID:2106 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.34e-14 | 12 | 255 | 8 | DOID:11720 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 3.46e-14 | 13 | 255 | 8 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.70e-13 | 15 | 255 | 8 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 2.92e-10 | 48 | 255 | 9 | DOID:423 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.09e-08 | 71 | 255 | 9 | DOID:0050700 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 4.72e-07 | 80 | 255 | 8 | DOID:12930 (implicated_via_orthology) | |
| Disease | monilethrix (is_implicated_in) | 6.38e-07 | 3 | 255 | 3 | DOID:0050472 (is_implicated_in) | |
| Disease | MONILETHRIX | 6.38e-07 | 3 | 255 | 3 | 158000 | |
| Disease | Beaded hair | 6.38e-07 | 3 | 255 | 3 | cv:C0546966 | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 6.38e-07 | 3 | 255 | 3 | DOID:0060535 (implicated_via_orthology) | |
| Disease | Monilethrix | 2.54e-06 | 4 | 255 | 3 | C0546966 | |
| Disease | visual impairment and progressive phthisis bulbi (implicated_via_orthology) | 2.54e-06 | 4 | 255 | 3 | DOID:0070356 (implicated_via_orthology) | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 6.30e-06 | 5 | 255 | 3 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 6.30e-06 | 5 | 255 | 3 | DOID:11252 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 6.30e-06 | 5 | 255 | 3 | DOID:0110197 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | MYH1 NET1 CYP19A1 SPTAN1 EFCAB13 HAPLN4 COG3 PTGS2 PIK3R4 PTPRC HSPA1B CNGA2 PLXNB1 ABCC1 RB1 SYNE1 UBR4 GRIN2D RFX2 GTF2A1 IGBP1 MTOR CHD5 MACF1 CPSF3 | 7.76e-06 | 1074 | 255 | 25 | C0006142 |
| Disease | Hypertrophic Cardiomyopathy | 9.85e-06 | 57 | 255 | 6 | C0007194 | |
| Disease | Hypertrophic obstructive cardiomyopathy | 5.97e-05 | 25 | 255 | 4 | C4551472 | |
| Disease | prostate cancer (is_implicated_in) | 7.33e-05 | 117 | 255 | 7 | DOID:10283 (is_implicated_in) | |
| Disease | hair disease (is_implicated_in) | 7.44e-05 | 2 | 255 | 2 | DOID:421 (is_implicated_in) | |
| Disease | upper respiratory tract disorder | 9.47e-05 | 28 | 255 | 4 | MONDO_0004867 | |
| Disease | Epileptic encephalopathy | 1.25e-04 | 30 | 255 | 4 | C0543888 | |
| Disease | collagen disease (implicated_via_orthology) | 1.32e-04 | 12 | 255 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | Cardiomyopathies | 1.42e-04 | 130 | 255 | 7 | C0878544 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.71e-04 | 13 | 255 | 3 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Nephronophthisis | 1.71e-04 | 13 | 255 | 3 | C0687120 | |
| Disease | growth hormone secreting pituitary adenoma (is_marker_for) | 2.22e-04 | 3 | 255 | 2 | DOID:6255 (is_marker_for) | |
| Disease | peripheral nervous system disease (biomarker_via_orthology) | 2.22e-04 | 3 | 255 | 2 | DOID:574 (biomarker_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.22e-04 | 3 | 255 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.22e-04 | 3 | 255 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | prolactinoma (is_marker_for) | 2.22e-04 | 3 | 255 | 2 | DOID:5394 (is_marker_for) | |
| Disease | sexual dimorphism measurement | FILIP1 CYP19A1 EFCAB13 SNAP47 STX1B SNX13 SPTBN5 EHBP1L1 AK5 KPNA3 DOCK3 PITPNM2 P4HA2 DNAH10 CPD NFS1 NPRL3 DNM3 MACF1 ERC2 KDM2A TNKS | 2.67e-04 | 1106 | 255 | 22 | EFO_0021796 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.78e-04 | 145 | 255 | 7 | DOID:1289 (implicated_via_orthology) | |
| Disease | Alzheimer's disease (is_marker_for) | 4.27e-04 | 257 | 255 | 9 | DOID:10652 (is_marker_for) | |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 4.41e-04 | 4 | 255 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 4.41e-04 | 4 | 255 | 2 | cv:C3495498 | |
| Disease | Caveolinopathy | 4.41e-04 | 4 | 255 | 2 | cv:C5679790 | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 4.41e-04 | 4 | 255 | 2 | 192600 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 4.41e-04 | 4 | 255 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | Glycogen phosphorylase kinase deficiency | 4.41e-04 | 4 | 255 | 2 | cv:C0268147 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 5.16e-04 | 43 | 255 | 4 | DOID:2476 (implicated_via_orthology) | |
| Disease | Chronic myeloproliferative disorder | 5.58e-04 | 19 | 255 | 3 | C1292778 | |
| Disease | disorder of pharynx | 6.68e-04 | 46 | 255 | 4 | MONDO_0020592 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 7.31e-04 | 5 | 255 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | Atrial Septal Defects | 7.31e-04 | 5 | 255 | 2 | C0018817 | |
| Disease | sleep efficiency | 7.31e-04 | 5 | 255 | 2 | EFO_0803364 | |
| Disease | Seckel syndrome | 8.70e-04 | 22 | 255 | 3 | C0265202 | |
| Disease | Herpetic meningoencephalitis | 1.09e-03 | 6 | 255 | 2 | C0019385 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.14e-03 | 53 | 255 | 4 | C1961099 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.35e-03 | 364 | 255 | 10 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Neoplastic Cell Transformation | 1.35e-03 | 139 | 255 | 6 | C0007621 | |
| Disease | Bladder Neoplasm | 1.40e-03 | 140 | 255 | 6 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.46e-03 | 141 | 255 | 6 | C0005684 | |
| Disease | dipeptidyl peptidase 2 measurement | 1.52e-03 | 7 | 255 | 2 | EFO_0020326 | |
| Disease | Frontotemporal Lobar Degeneration | 1.52e-03 | 7 | 255 | 2 | C0751072 | |
| Disease | Herpes encephalitis | 1.52e-03 | 7 | 255 | 2 | C0276226 | |
| Disease | Obstructive asymmetric septal hypertrophy | 1.52e-03 | 7 | 255 | 2 | C0597124 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.52e-03 | 7 | 255 | 2 | C0751337 | |
| Disease | Nephronophthisis, familial juvenile | 1.52e-03 | 7 | 255 | 2 | C1855681 | |
| Disease | laurylcarnitine measurement | 1.52e-03 | 7 | 255 | 2 | EFO_0021041 | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 1.52e-03 | 7 | 255 | 2 | C0700053 | |
| Disease | hemoglobin subunit zeta measurement | 1.52e-03 | 7 | 255 | 2 | EFO_0801670 | |
| Disease | mean corpuscular hemoglobin concentration | MYH2 ATR MARK3 SNX13 EHBP1L1 PTPRC NFKB1 VPS13A CUL1 ABCC1 EP400 RTTN CASP10 SKP2 GTF2A1 TBK1 NPRL3 MACF1 RPA1 ENO2 | 1.59e-03 | 1105 | 255 | 20 | EFO_0004528 |
| Disease | Amyotrophic Lateral Sclerosis | 1.60e-03 | 58 | 255 | 4 | C0002736 | |
| Disease | aortic measurement | 1.61e-03 | 251 | 255 | 8 | EFO_0020865 | |
| Disease | mean reticulocyte volume | ATR MARK3 PTPRC AK5 NFKB1 VPS13A TLN2 ABCC1 EP400 RTTN SKP2 CENPQ GTF3C1 MTOR NPRL3 RPA1 | 1.71e-03 | 799 | 255 | 16 | EFO_0010701 |
| Disease | Amyotrophic Lateral Sclerosis With Dementia | 1.97e-03 | 29 | 255 | 3 | C0393554 | |
| Disease | Frontotemporal Dementia With Motor Neuron Disease | 2.01e-03 | 8 | 255 | 2 | C3888102 | |
| Disease | melanoma (implicated_via_orthology) | 2.01e-03 | 8 | 255 | 2 | DOID:1909 (implicated_via_orthology) | |
| Disease | placental insufficiency (biomarker_via_orthology) | 2.01e-03 | 8 | 255 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 2.01e-03 | 8 | 255 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | anxiety disorder | 2.18e-03 | 30 | 255 | 3 | EFO_0006788 | |
| Disease | Amyotrophic Lateral Sclerosis, Guam Form | 2.40e-03 | 31 | 255 | 3 | C0543859 | |
| Disease | lung cancer (implicated_via_orthology) | 2.57e-03 | 9 | 255 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | Major depression, single episode | 2.57e-03 | 9 | 255 | 2 | C0024517 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.57e-03 | 9 | 255 | 2 | C3502809 | |
| Disease | Carcinoma, Small Cell | 2.57e-03 | 9 | 255 | 2 | C0262584 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 2.57e-03 | 9 | 255 | 2 | C0949658 | |
| Disease | glycogen storage disease (is_implicated_in) | 2.57e-03 | 9 | 255 | 2 | DOID:2747 (is_implicated_in) | |
| Disease | microcephaly (implicated_via_orthology) | 2.63e-03 | 32 | 255 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | Microcephaly | 2.73e-03 | 67 | 255 | 4 | C0025958 | |
| Disease | Heart Failure, Diastolic | 2.87e-03 | 33 | 255 | 3 | C1135196 | |
| Disease | Malignant neoplasm of prostate | ATR CYP19A1 CHD3 TNFRSF21 PTGS2 PTPRC HPGD SPON2 USP7 HSPA1A RB1 LAMB2 RNASEL | 2.92e-03 | 616 | 255 | 13 | C0376358 |
| Disease | Prostatic Neoplasms | ATR CYP19A1 CHD3 TNFRSF21 PTGS2 PTPRC HPGD SPON2 USP7 HSPA1A RB1 LAMB2 RNASEL | 2.92e-03 | 616 | 255 | 13 | C0033578 |
| Disease | circadian rhythm | 3.02e-03 | 163 | 255 | 6 | EFO_0004354 | |
| Disease | epilepsy (implicated_via_orthology) | 3.02e-03 | 163 | 255 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Primary dilated cardiomyopathy | 3.13e-03 | 34 | 255 | 3 | cv:C0007193 | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 3.20e-03 | 10 | 255 | 2 | cv:C5675009 | |
| Disease | Adenocarcinoma | 3.41e-03 | 116 | 255 | 5 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 3.41e-03 | 116 | 255 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.41e-03 | 116 | 255 | 5 | C0205645 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QKMEEDGSTVLGLLE | 561 | O75410 | |
| KEADLSMFDLIGLEN | 1406 | Q96L91 | |
| KDRDDIVSMDLGLIN | 586 | Q96Q91 | |
| LQGELILKSAMSEIE | 866 | Q6ZSZ5 | |
| ENLKSMEEIQGLTDL | 921 | Q7Z7A1 | |
| NEEGLALLQEEIDKM | 151 | Q7L2Z9 | |
| LTDEEMAALGKEELV | 11 | Q15834 | |
| LNQLEELLSDMKADV | 1861 | Q8TDI0 | |
| DALEKLNMGITDLQG | 321 | P0C0L5 | |
| EGIMNLGTLKEDISE | 1231 | Q68DQ2 | |
| SKRLEIMLQDIFGED | 611 | Q9UKF6 | |
| DIGTAMAKDERVNLL | 256 | P49419 | |
| LLTKELDDMGLDSSQ | 891 | Q6ZN30 | |
| LAIVEKLMEAGAQIE | 166 | Q15327 | |
| IAKMEEQGLADASLL | 436 | Q9UBB4 | |
| TLDMLDLGAAKANLE | 121 | P30049 | |
| LNDLQMIDGKEADTD | 71 | A0A1B0GW35 | |
| MGIKNRNEAELTEEL | 1191 | Q7Z2Y8 | |
| KDLGLDSLDQVEIIM | 106 | O14561 | |
| AQLLTEMDGIEQLKD | 751 | Q8NB90 | |
| EMDGIEQLKDVTILA | 756 | Q8NB90 | |
| VITILDNDDLAGMDI | 5121 | Q8WXG9 | |
| RLLDVQDAEIMAGKS | 5776 | Q8WXG9 | |
| IENIDEDFRDGLKLM | 71 | O43707 | |
| ELLEKDGMAFQEALD | 141 | P78545 | |
| AQALADGLMELSKED | 511 | Q008S8 | |
| MLLGATAVEDKLQEG | 641 | Q8TF62 | |
| LLDEDKDGMVQLSLA | 681 | A6NHC0 | |
| TLNDELEIIEGMKFD | 206 | P10809 | |
| MAAALAELEGLLAKA | 941 | Q96M86 | |
| LNMGKEEASLEEVLV | 106 | Q96HY7 | |
| EDMDQALVDLGVLSD | 61 | O95424 | |
| MDLESQIESLKEELG | 221 | Q13515 | |
| LMAEIGEDLDKSDVS | 96 | O15519 | |
| GLSVVEQEKLDNLML | 81 | P09104 | |
| EQEKLDNLMLELDGT | 86 | P09104 | |
| NSLLKLEGDDRLDMN | 1581 | O14578 | |
| EDEGKAMLASLRSEL | 811 | Q8NB25 | |
| GDGSLEKELAIDNIM | 311 | Q3KR37 | |
| ELQALDDMVSADIGI | 191 | Q5T7V8 | |
| GLSEMELEDVLALDN | 671 | Q9ULI1 | |
| AKGEVLQMEDDLVIS | 201 | P06400 | |
| LEEEIQMLKSNGALS | 401 | Q8IUD2 | |
| DVVIMLLGNKIDLDN | 136 | Q5JT25 | |
| LEEDSLLSGKAQGMV | 926 | A6NNM3 | |
| LVMSANLKAAEEELV | 1466 | A6NNM3 | |
| LEEDSLLSGKAQGMV | 926 | A6NJZ7 | |
| LVMSANLKAAEEELV | 1466 | A6NJZ7 | |
| LGELAMVLDQIEAEL | 231 | Q96MZ0 | |
| KNLTEEMAGLDEIIA | 976 | P12883 | |
| EGDLKLTQESIMDLE | 1056 | P12883 | |
| EAKTQAILLEMVGDL | 216 | Q8WUA2 | |
| LTKMEGLESCINLEE | 921 | Q6ZRR7 | |
| EMSRGEQDLIEDLKL | 181 | Q7Z628 | |
| FKEDTLLLIAEVMGE | 306 | Q96K31 | |
| DNDLQLAMELSAKEL | 551 | Q8IZ07 | |
| GSDIIKLLSADMNAD | 91 | P28039 | |
| EKLLRAVADGDLEMV | 671 | Q96NW4 | |
| LLTSLEQEMEELGKV | 451 | Q9Y5S8 | |
| LEEQLKSLGEQMAAE | 286 | Q6NSJ2 | |
| IEAELGILMEKSTGN | 256 | Q7RTS5 | |
| DKRVDDMLAAGLLEE | 241 | Q9H3H1 | |
| VLDGLKNILIMAGDE | 431 | O00505 | |
| ARTDLEMQIEGLKEE | 196 | P08727 | |
| IERDDIDMLKELGSL | 61 | Q52LA3 | |
| DLGLEASKFIEDLNM | 6 | Q9UGP4 | |
| VEGESLLMALKDVAL | 361 | Q9Y697 | |
| QDEEDRELIMKLLGS | 886 | O60524 | |
| LELLKEAMVASLGDT | 441 | Q9Y6K8 | |
| EIGSNKIEDAGMQLL | 866 | P59045 | |
| KLDLMDEGTDARDVL | 206 | Q05193 | |
| SVGMAKAALEALDEL | 201 | P46020 | |
| EVMNSKLGLDIEIAT | 391 | O43790 | |
| EKEVEDGLMLQDLVS | 1511 | O60318 | |
| KLDLMDEGTDARDVL | 206 | Q9UQ16 | |
| LLETKTMLEDQLEGT | 356 | Q3V6T2 | |
| LLQGLMDSVEAKQIE | 881 | Q5VYK3 | |
| MGDKSENVQDLLLLD | 381 | P0DMV9 | |
| MELEADNAGITEILE | 106 | Q9NXR8 | |
| LTEEMAGLDETIAKL | 981 | P13535 | |
| EQRGLASKAAELEME | 36 | Q9UHV9 | |
| IALLNEGEELEELMK | 251 | Q14651 | |
| SVEGENLDLAMSKEE | 1401 | O43157 | |
| LDLLEKAAEMLSQLD | 46 | P78318 | |
| SDLMTINLLGKELAD | 731 | Q9HCI6 | |
| MKDEVALLAAVTLLG | 1 | Q16873 | |
| IMLGDEAALLEQKEL | 286 | Q9BW27 | |
| VKNLTEEMAGLDETI | 981 | Q9UKX2 | |
| LEGDLKLAQESIMDI | 1061 | Q9UKX2 | |
| EAKLILALQDEVSAM | 166 | Q12980 | |
| ERLVEDLIQESMAKG | 201 | Q9NX36 | |
| LMESGANKLQEEVLI | 1391 | Q8N3D4 | |
| GDMLLEKIQSALADI | 111 | Q13503 | |
| VLELADAGDLSQMIK | 121 | Q9HC98 | |
| QLDEMAELGFKEETL | 1301 | Q5T7B8 | |
| LDDRKATVDMLQAEG | 1521 | O94854 | |
| GMEELQAQLEKELEG | 256 | P16050 | |
| ELTGEKEMSAELEAL | 466 | P35354 | |
| LESKAAQLDGLEARM | 1766 | P55268 | |
| EMADLVAVTKSDGDL | 281 | Q8IVH4 | |
| ELEIELQSQLSMKAG | 331 | P19012 | |
| KLGVIDSERMDFELL | 671 | Q9UGL1 | |
| KMDNSRELDVDGIIA | 276 | Q9NSB4 | |
| NLTEEMAGLDETIAK | 981 | P12882 | |
| TLGEKMTEAEVEQLL | 161 | P12829 | |
| EMITGLEDLKALQNL | 271 | Q96M69 | |
| DLEDEIQMLKANGVL | 396 | O15083 | |
| GLSMENIRELEKEAQ | 236 | Q9BZ72 | |
| EQMGLLRDEALAEVK | 321 | Q96FC9 | |
| DLLKAGAEVNVLNDM | 66 | Q9BXW6 | |
| KLDLMDEGTDARDVL | 206 | P50570 | |
| GEEENTILMAKERLE | 11 | Q6NXR0 | |
| TEEVINEGLMDEKLL | 2351 | Q9UPN3 | |
| EVGTEAKMLLLARED | 246 | Q9BRP4 | |
| QLSEEGEIVDLLLMK | 2406 | Q7Z442 | |
| LEDAGKMLNETVLVS | 1921 | Q96RW7 | |
| DEDEIGAAKALMRLQ | 126 | O15460 | |
| VDLEMTGLDIEKDQI | 46 | Q9Y3B8 | |
| LMDLLAKDDQNGEAE | 151 | P61296 | |
| LEGKEGSMENEIAVL | 56 | Q14012 | |
| GVLSEMKEQGLLDAV | 61 | Q9UP65 | |
| LMELEVLKSAEAVGV | 96 | P27694 | |
| IDLLIIGSKVDMNDF | 186 | Q15825 | |
| DVKAVLGTLLNLMED | 801 | Q13535 | |
| DQIIKELDSGAEGLM | 756 | Q05DH4 | |
| SGLEIMDEDQLIKDV | 6 | Q86VG3 | |
| KESLSMDLELNGLES | 356 | Q9Y2K7 | |
| EAELIDKLDSMVSEG | 1136 | Q8IZD9 | |
| DALNEAIDKREEGIM | 416 | P49917 | |
| DLVMRKALEDDVIDG | 371 | P11511 | |
| DTILADEMGLGKTIQ | 756 | Q12873 | |
| DILLKGFTSLGMEEE | 86 | Q96JB2 | |
| TNLLKDGEDLMDESV | 101 | Q13616 | |
| IMDEDQSKLAGLLDL | 331 | P62508 | |
| QVMGDILDKLSEETG | 1781 | Q8N3K9 | |
| LMEENSKLEALLGSA | 221 | P54257 | |
| GLLRDEALAEVKDME | 326 | A8MPP1 | |
| IKDLSAENGLESLML | 906 | O75976 | |
| QMGLLRDEALAEVKD | 341 | Q92771 | |
| LRGDADNDMVKIENL | 2041 | Q9BZC7 | |
| MEAFLTLTDGDLKEL | 801 | Q68DC2 | |
| LVLDEMDQLDSKGQD | 281 | Q99741 | |
| EEKTGMLANVVLLDS | 231 | Q5TB80 | |
| ADLLEGDMIAGKNLE | 681 | Q8IY85 | |
| LTEEELGTAELLMNA | 2806 | Q99698 | |
| MTSDLIQEKLVALGD | 446 | Q5I0G3 | |
| RDLKAENLLLDGDMN | 181 | Q9P0L2 | |
| ENLLLDGDMNIKIAD | 186 | Q9P0L2 | |
| LLLDADMNIKIADFG | 181 | Q7KZI7 | |
| AENLLLDADMNIKIA | 181 | P27448 | |
| GELQEDSGLMALAKL | 161 | Q9BUP0 | |
| LLGQAEDKAEVDMDT | 926 | Q14204 | |
| VKDVLLVAQGEMALE | 1446 | Q14204 | |
| TNELEDDAGMVKLDL | 146 | Q86UW8 | |
| ELSEGIDSENLKDMI | 121 | Q92851 | |
| QMGNLEDAETKDLLV | 1376 | Q8WYP5 | |
| MGDKSENVQDLLLLD | 381 | P0DMV8 | |
| ESSGLMDLLEEKADL | 416 | A8MQT2 | |
| DGLELNKTALDTMEA | 2191 | Q9NYQ7 | |
| LEAEGSMKQALGELQ | 461 | Q8NFF5 | |
| QKAEALMRELDEEGS | 161 | Q9BRJ6 | |
| EALTKAEAGRMELEL | 11 | Q86T23 | |
| AKMLDALLEGEIEDL | 2321 | Q8IVF4 | |
| LEGTLLEFTKDMDQL | 451 | A0AV02 | |
| EAEGLMKVEAARLSA | 416 | Q9HBR0 | |
| NGLLAAMEEAIKIAE | 2341 | Q92736 | |
| LEKLMEEIVELAESG | 3211 | Q92736 | |
| KAEARGDMSEAELLI | 3341 | Q92736 | |
| MAERAALEELVKLQG | 1 | P12081 | |
| EFANLLDELLMKING | 2791 | Q8TDX9 | |
| DLDLTAEGDLNIIMA | 436 | Q96LT7 | |
| AEGDLNIIMALAEKI | 441 | Q96LT7 | |
| LMLATLDENEEVIDG | 56 | Q03701 | |
| DALEKLNMGITDLQG | 321 | P0C0L4 | |
| DKEQDLLQAGELFME | 191 | Q9UNU6 | |
| EVMNSKLGLDIEIAT | 396 | P78385 | |
| SVGMAKAALEAIDEL | 201 | P46019 | |
| EDSERLMEQQGALLK | 281 | Q5BJF6 | |
| LLAEDDVVGIEKMSS | 406 | O15403 | |
| KARDLLDAELTAMAG | 1566 | P42345 | |
| SLLSALLAEMDKVEG | 686 | P33527 | |
| TLIEDDALNGAIMKI | 231 | P15428 | |
| DVSMLSDKEELVGAE | 151 | Q6KF10 | |
| SGLMDLLEEKADLRE | 446 | A7E2F4 | |
| SGLDMLDSLDVVNKD | 56 | P53609 | |
| QDVLDKLADMGIAIR | 446 | Q9Y3I0 | |
| EDGVIKELSIAMQLL | 1916 | Q86VV8 | |
| MNIIKLSDNIGELEA | 291 | Q9Y5W8 | |
| EKLRDLQGAMDDLDA | 2691 | P46939 | |
| EEMALRGKDAAEIVL | 571 | Q96R06 | |
| LMKEIEAAGEALQSV | 106 | Q9BUD6 | |
| LDLAESDAMEGLLKA | 171 | Q9BZL4 | |
| GLMEDTTQLETDKLA | 496 | O75509 | |
| MKGLALEAESELERQ | 421 | Q5SQN1 | |
| QDLADLLETGQEKMA | 6596 | Q8NF91 | |
| SKEDLIQLLSIMEGE | 76 | Q7Z7B0 | |
| DMTSDLVNEGKELIR | 566 | Q68DH5 | |
| ASLSLTLLDKDDMGD | 676 | P48378 | |
| LVMSANLKAAEEELV | 1466 | Q9UFD9 | |
| VLQELTEKDLVEMGL | 46 | Q8IVG5 | |
| IALIKMDLSDLGEAA | 16 | Q9Y2K3 | |
| DDLEKNIADLMTQAG | 46 | O75506 | |
| TELMLEGDDDAVSLL | 2126 | Q8NFP9 | |
| LLGDNEKMNLSDVEL | 576 | Q8NEB9 | |
| QEELGDLVDKEMAAT | 776 | O00291 | |
| VEVLKILLDEMGADV | 181 | Q05823 | |
| NLTEEMAGLDETIAK | 981 | Q9Y623 | |
| EMAIETVGQAKDELL | 1056 | Q8NEZ3 | |
| VLEALDEMGDLLQLK | 516 | Q9NUV7 | |
| NDLQLKDMSVVEGGL | 986 | Q15477 | |
| DDLIMAKDDLSGADI | 381 | P62191 | |
| TEEMAGLDEIIAKLT | 981 | P13533 | |
| EEAKSLRLGMQEDLE | 651 | Q68D10 | |
| MLEEKGVQLDSAGLE | 456 | Q5JTZ9 | |
| KNLVALEEGLLDTAM | 2701 | Q9NRC6 | |
| EEERGNAADLLKLVM | 1811 | Q6Q759 | |
| ILSLMAQELGISEKD | 161 | Q9H6E4 | |
| IMLKAQSIELEEGSI | 391 | Q0P6D6 | |
| ELMGVLALSKEEQER | 586 | Q0VD83 | |
| AALAEVADEKMLSGL | 676 | Q15003 | |
| AAQELEELSKMTGGL | 441 | A8K7I4 | |
| DLADLQMVTDETGKE | 186 | Q6ZU45 | |
| EILMKEGLLDENEVA | 576 | Q16280 | |
| LMKDNLIDEELARAG | 606 | Q16281 | |
| SQGMTEEEEDKLLAL | 776 | Q99570 | |
| ELLSGMGVSALEKEE | 31 | Q13309 | |
| DDGVDEQVLMELKTL | 31 | P52655 | |
| REEGKALNEEMELNL | 226 | Q86WT6 | |
| LQMDFGLDLVTELKE | 1651 | Q63HN8 | |
| INDDMLEGLEKLEIL | 521 | O15455 | |
| DSLGDEMLAAALLKA | 31 | P17036 | |
| NISEIKIEGLDSEMI | 1071 | Q96RL7 | |
| IMTLNGEAVSDLDLK | 941 | Q8IVF5 | |
| GEAVSDLDLKQMEAL | 946 | Q8IVF5 | |
| LTNEMKEAGNLEGIL | 636 | Q9NXC5 | |
| ILILKNMEGVLTDAD | 411 | Q9UJ98 | |
| LTEEELQTDLGMKSG | 446 | Q6SZW1 | |
| QLEGLMKEINDLAES | 3106 | Q15413 | |
| NEELEDMLESGKLAI | 161 | P61266 | |
| MLLQETTGELEAAKA | 181 | P42226 | |
| QGMLDVADESLTDLE | 186 | Q92791 | |
| NKVAEDLESEGLMAE | 1151 | Q13813 | |
| EDLGAAMEEALILDN | 2266 | Q13813 | |
| EAARSGNEEKLMALL | 341 | O95271 | |
| SDFKDLIGQILMEVL | 196 | O95155 | |
| DKVGIEAAEMLLANL | 271 | O00442 | |
| EEILASVMIKNLDTG | 351 | Q5JSH3 | |
| RNGLLLEELEEMKVA | 1681 | Q9UKX3 | |
| EIIGFKAEMSDLDDL | 246 | Q8IYM2 | |
| LNEDLAKILGMSLEE | 696 | O00534 | |
| KIIILDEADSMTDGA | 136 | P35250 | |
| LNVTEGAMQDLLKEI | 36 | A6NFE2 | |
| GQAALLDTAKMLVAE | 96 | Q96MT0 | |
| NVLEAMISGELDILK | 326 | O43615 | |
| KLIANDDMAELLLGE | 36 | Q86TV6 | |
| DDMAELLLGESKLEQ | 41 | Q86TV6 | |
| DNALRELETVKGMLD | 1366 | Q9Y4G6 | |
| EGIMAFADKTLLELL | 206 | Q9NWZ5 | |
| MKLLSSEDEVLVGNA | 611 | Q9H892 | |
| LDLRDNKLGDLDAMI | 836 | O60346 | |
| MAKLEELEEIDLSGN | 1056 | O60346 | |
| AALKEEQRLDGMLLD | 296 | O14948 | |
| VDLELDALEGKELMQ | 161 | Q96DT7 | |
| MDALESLLDEVALEG | 1 | Q12789 | |
| EELLKQAESVMQDLG | 1596 | Q14669 | |
| EDDSGMELLVNNKII | 4401 | Q5T4S7 | |
| LDLLQVEGMKIEEES | 101 | A5D8V6 | |
| IDAMLEGLEAENKVD | 866 | P08575 | |
| DSLLDSVVGLKQMLE | 1471 | Q69YN4 | |
| VLMGLLELCADAEKQ | 1221 | Q9Y4E6 | |
| VSLDKALDELMDGDI | 751 | Q93009 | |
| ALDELMDGDIIVFQK | 756 | Q93009 | |
| IEDEGVLDKMLDQST | 586 | P53814 | |
| SLNSIVDVEDLGKIM | 261 | Q6NUM6 | |
| MKINLEAAELGEISD | 486 | Q9UHD2 | |
| DLLLKQMELQDDGIT | 806 | Q9P2D8 | |
| MEETKAQDILGAVTL | 76 | P40225 | |
| EDTLKALEMGAVEIL | 306 | P62495 | |
| VLDGLSNILKMAEDE | 431 | O00629 | |
| DAQELLDGIKESMEQ | 436 | Q96M32 | |
| EVMNSKLGLDIEIAT | 391 | Q14533 | |
| EVLLLDMSLDDGDSK | 201 | Q13224 | |
| ALLQFLGDDEIEMLE | 806 | O15399 | |
| DLLAQGDMKQLAEDV | 801 | P19838 | |
| AALEDLNLSILKAMG | 101 | Q8N987 |